<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Primary_Ciliary_Dyskinesia - Disorder Mechanisms</title>
    <style>
        :root {
            --primary: #0f766e;
            --primary-light: #14b8a6;
            --primary-dark: #0d5c56;
            --secondary: #6366f1;
            --bg: #f0fdfa;
            --card-bg: #ffffff;
            --text: #134e4a;
            --text-muted: #5f7a78;
            --border: #ccfbf1;
            --accent-orange: #f59e0b;
            --accent-rose: #f43f5e;
            --accent-violet: #8b5cf6;
            --accent-sky: #0ea5e9;
            --banner-bg: #fef3c7;
            --banner-border: #f59e0b;
            --banner-text: #92400e;
        }

        * { box-sizing: border-box; margin: 0; padding: 0; }

        body {
            font-family: 'Segoe UI', system-ui, -apple-system, sans-serif;
            background: var(--bg);
            color: var(--text);
            line-height: 1.7;
        }

        .notice-banner {
            background: var(--banner-bg);
            color: var(--banner-text);
            border-bottom: 1px solid var(--banner-border);
            padding: 12px 16px;
            text-align: center;
            font-size: 0.95rem;
            cursor: pointer;
        }

        .container {
            max-width: 1100px;
            margin: 0 auto;
            padding: 24px;
        }

        /* Header */
        .page-header {
            background: linear-gradient(135deg, var(--primary) 0%, var(--primary-dark) 100%);
            color: white;
            padding: 40px 32px;
            border-radius: 16px;
            margin-bottom: 24px;
            position: relative;
            overflow: hidden;
        }

        .page-header::before {
            content: '';
            position: absolute;
            top: -50%;
            right: -20%;
            width: 400px;
            height: 400px;
            background: rgba(255,255,255,0.05);
            border-radius: 50%;
        }

        .page-header h1 {
            font-size: 2.2rem;
            font-weight: 700;
            margin-bottom: 12px;
            position: relative;
        }

        .header-meta {
            display: flex;
            flex-wrap: wrap;
            gap: 12px;
            align-items: center;
            position: relative;
        }

        .badge {
            display: inline-flex;
            align-items: center;
            padding: 6px 14px;
            border-radius: 20px;
            font-size: 0.85rem;
            font-weight: 500;
        }

        .badge-category {
            background: rgba(255,255,255,0.2);
            color: white;
        }

        .badge-mondo {
            background: var(--accent-sky);
            color: white;
        }

        .badge-mondo a {
            color: inherit;
            text-decoration: none;
        }

        .badge-mondo a:hover {
            text-decoration: underline;
        }

        /* Navigation */
        .breadcrumb {
            margin-bottom: 16px;
            font-size: 0.9rem;
        }

        .breadcrumb a {
            color: var(--primary);
            text-decoration: none;
        }

        .breadcrumb a:hover {
            text-decoration: underline;
        }

        .breadcrumb span {
            color: var(--text-muted);
        }

        /* Cards */
        .card {
            background: var(--card-bg);
            border-radius: 12px;
            border: 1px solid var(--border);
            padding: 24px;
            margin-bottom: 20px;
            box-shadow: 0 1px 3px rgba(0,0,0,0.04);
        }

        .card-header {
            display: flex;
            align-items: center;
            gap: 12px;
            margin-bottom: 16px;
            padding-bottom: 12px;
            border-bottom: 2px solid var(--border);
        }

        .card-icon {
            width: 36px;
            height: 36px;
            border-radius: 8px;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 1.2rem;
        }

        .card-title {
            font-size: 1.1rem;
            font-weight: 600;
            color: var(--text);
        }

        .card-count {
            margin-left: auto;
            background: var(--bg);
            padding: 4px 12px;
            border-radius: 12px;
            font-size: 0.8rem;
            color: var(--text-muted);
        }

        /* Sections */
        .section-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(320px, 1fr));
            gap: 20px;
        }

        /* Tags */
        .tag-list {
            display: flex;
            flex-wrap: wrap;
            gap: 8px;
        }

        .tag {
            padding: 6px 12px;
            border-radius: 6px;
            font-size: 0.85rem;
            font-weight: 500;
        }

        .tag-cell {
            background: #fce7f3;
            color: #9d174d;
        }

        .tag-gene {
            background: #dbeafe;
            color: #1e40af;
        }

        .tag-treatment {
            background: #ede9fe;
            color: #5b21b6;
        }

        .tag-env {
            background: #ccfbf1;
            color: #0f766e;
        }

        .tag-location {
            background: #e0e7ff;
            color: #3730a3;
        }

        .tag-component {
            background: #f0fdf4;
            color: #166534;
        }

        .tag-complex {
            background: #faf5ff;
            color: #7e22ce;
        }

        .tag-bio {
            background: #fef3c7;
            color: #92400e;
        }

        .tag-modifier {
            background: #fee2e2;
            color: #991b1b;
            text-transform: uppercase;
            letter-spacing: 0.02em;
        }

        .tag-parent {
            background: #e0e7ff;
            color: #3730a3;
        }

        .tag-classification {
            background: #fef3c7;
            color: #92400e;
        }

        .tag-mechanistic {
            background: #dbeafe;
            color: #1e40af;
        }

        .linkout {
            color: inherit;
            margin-left: 6px;
            font-size: 0.75rem;
            text-decoration: none;
            border-bottom: 1px dotted rgba(0, 0, 0, 0.2);
        }

        .classification-category {
            font-size: 0.75rem;
            font-weight: 600;
            text-transform: uppercase;
            letter-spacing: 0.05em;
            color: var(--text-muted);
            margin-bottom: 8px;
        }

        .mapping-section {
            margin-bottom: 16px;
        }

        .mapping-item {
            padding: 10px 12px;
            border: 1px solid #e2e8f0;
            border-radius: 8px;
            background: #ffffff;
            margin-bottom: 10px;
        }

        .mapping-title {
            font-size: 0.9rem;
            font-weight: 600;
            display: flex;
            flex-wrap: wrap;
            gap: 8px;
            align-items: baseline;
            margin-bottom: 6px;
        }

        .mapping-label {
            color: var(--text-muted);
            font-weight: 500;
        }

        .mapping-notes {
            font-size: 0.85rem;
            color: var(--text-muted);
            margin-top: 6px;
        }

        .mapping-tree {
            margin-top: 6px;
            font-size: 0.75rem;
            color: var(--text-muted);
            list-style: none;
            padding-left: 0;
        }

        .mapping-tree li {
            margin: 2px 0;
        }

        /* Evidence styling */
        .evidence-toggle {
            cursor: pointer;
            font-size: 0.8rem;
            color: var(--text-muted);
            margin-top: 10px;
            user-select: none;
        }

        .evidence-toggle:hover {
            color: var(--primary);
        }

        .evidence-list {
            margin-top: 10px;
            padding-left: 0;
        }

        .evidence-item {
            padding: 12px 14px;
            background: #f8fafc;
            border-radius: 8px;
            margin-bottom: 8px;
            border: 1px solid #e2e8f0;
            font-size: 0.9rem;
        }

        .evidence-header {
            display: flex;
            align-items: center;
            flex-wrap: wrap;
            gap: 8px;
        }

        .evidence-ref {
            font-weight: 600;
            color: var(--secondary);
        }

        .evidence-ref a {
            color: inherit;
            text-decoration: none;
        }

        .evidence-ref a:hover {
            text-decoration: underline;
        }

        .evidence-support {
            font-size: 0.7rem;
            padding: 2px 8px;
            border-radius: 4px;
            font-weight: 600;
            text-transform: uppercase;
            transition: transform 120ms ease, box-shadow 120ms ease;
        }

        .support-SUPPORT { background: #dcfce7; color: #166534; }
        .support-PARTIAL { background: #fef3c7; color: #92400e; }
        .support-REFUTE { background: #fee2e2; color: #991b1b; }
        .support-NO_EVIDENCE { background: #f1f5f9; color: #64748b; }
        .support-WRONG_STATEMENT { background: #fecaca; color: #7f1d1d; }

        .evidence-source {
            font-size: 0.7rem;
            padding: 2px 8px;
            border-radius: 4px;
            font-weight: 600;
            text-transform: uppercase;
            background: #e2e8f0;
            color: #334155;
            transition: transform 120ms ease, box-shadow 120ms ease;
        }

        .evidence-support:hover,
        .evidence-source:hover {
            transform: translateY(-1px);
            box-shadow: 0 4px 10px rgba(0,0,0,0.08);
        }

        .source-HUMAN_CLINICAL { background: #e0f2fe; color: #075985; }
        .source-MODEL_ORGANISM { background: #fef9c3; color: #854d0e; }
        .source-IN_VITRO { background: #ede9fe; color: #5b21b6; }
        .source-COMPUTATIONAL { background: #cffafe; color: #0e7490; }
        .source-OTHER { background: #e5e7eb; color: #374151; }

        .evidence-snippet {
            font-size: 0.85rem;
            color: var(--text-muted);
            margin-top: 8px;
            padding-left: 12px;
            border-left: 2px solid #cbd5e1;
            font-style: italic;
            line-height: 1.5;
        }

        .evidence-explanation {
            font-size: 0.85rem;
            color: var(--text);
            margin-top: 6px;
            line-height: 1.5;
        }

        .evidence-more {
            font-size: 0.8rem;
            color: var(--text-muted);
            margin-top: 6px;
            font-style: italic;
        }

        .findings-section {
            margin-top: 12px;
        }

        .findings-title {
            font-size: 0.75rem;
            font-weight: 600;
            text-transform: uppercase;
            letter-spacing: 0.04em;
            color: var(--text-muted);
            margin-bottom: 6px;
        }

        .finding-item {
            padding: 10px 12px;
            background: #f8fafc;
            border-radius: 8px;
            margin-bottom: 8px;
            border: 1px solid #e2e8f0;
            font-size: 0.9rem;
        }

        .finding-statement {
            font-weight: 600;
            color: var(--text);
            margin-bottom: 6px;
            line-height: 1.5;
        }

        .finding-supporting {
            font-size: 0.85rem;
            color: var(--text-muted);
            margin-top: 6px;
            padding-left: 12px;
            border-left: 2px solid #cbd5e1;
            font-style: italic;
            line-height: 1.5;
        }

        /* Item containers with evidence */
        .item-box {
            padding: 16px;
            border-radius: 10px;
            margin-bottom: 12px;
        }

        .item-name {
            font-weight: 600;
            margin-bottom: 6px;
        }

        .item-desc {
            font-size: 0.9rem;
            line-height: 1.6;
            margin-bottom: 8px;
        }

        .item-meta {
            display: flex;
            flex-wrap: wrap;
            gap: 6px;
            margin-top: 8px;
        }

        /* Definitions */
        .definition-box {
            background: #ecfeff;
            border-left: 4px solid #0ea5e9;
        }
        .definition-box .item-name { color: #0c4a6e; }
        .definition-box .item-desc { color: #075985; }

        /* Inheritance */
        .inheritance-box {
            background: #fef9c3;
            border-left: 4px solid #ca8a04;
        }
        .inheritance-box .item-name { color: #92400e; }
        .inheritance-box .item-desc { color: #92400e; }

        .criteria-block {
            margin-top: 12px;
            padding: 12px;
            border-radius: 8px;
            border: 1px solid #bae6fd;
            background: rgba(255, 255, 255, 0.7);
        }

        .criteria-title {
            font-weight: 600;
            color: #0c4a6e;
            margin-bottom: 6px;
        }

        .criteria-meta {
            font-size: 0.8rem;
            color: var(--text-muted);
            margin-bottom: 8px;
        }

        .criteria-header {
            font-size: 0.75rem;
            text-transform: uppercase;
            letter-spacing: 0.04em;
            color: #0284c7;
            margin-top: 8px;
        }

        .criteria-list {
            margin-left: 18px;
            font-size: 0.9rem;
            line-height: 1.5;
            color: #0f172a;
        }

        .criteria-list li {
            margin-bottom: 6px;
        }

        .criteria-detail {
            display: block;
            font-size: 0.85rem;
            color: var(--text-muted);
        }

        /* Pathophysiology */
        .pathophys-box {
            background: linear-gradient(135deg, #fef3c7 0%, #fef9c3 100%);
            border-left: 4px solid var(--accent-orange);
        }
        .pathophys-box .item-name { color: #92400e; }
        .pathophys-box .item-desc { color: #78350f; }

        /* Histopathology */
        .histopathology-box {
            background: #fff7ed;
            border-left: 4px solid #fb923c;
        }
        .histopathology-box .item-name { color: #9a3412; }
        .histopathology-box .item-desc { color: #c2410c; }

        .histopathology-freq {
            font-size: 0.75rem;
            padding: 2px 8px;
            border-radius: 10px;
            background: #ffedd5;
            color: #c2410c;
        }

        /* Phenotypes */
        .phenotype-box {
            background: #f0fdf4;
            border-left: 4px solid #22c55e;
        }
        .phenotype-box .item-name { color: #166534; }
        .phenotype-box .item-desc { color: #15803d; }

        .phenotype-freq {
            font-size: 0.75rem;
            padding: 2px 8px;
            border-radius: 10px;
            background: #dcfce7;
            color: #15803d;
        }

        .phenotype-category {
            font-size: 0.75rem;
            color: #4ade80;
        }

        .phenotype-id a {
            font-size: 0.8rem;
            color: var(--secondary);
            text-decoration: none;
        }

        .phenotype-id a:hover {
            text-decoration: underline;
        }

        /* Phenotype TOC strip */
        .pheno-toc {
            display: flex;
            flex-wrap: wrap;
            gap: 6px;
            padding: 10px 0 6px 0;
            border-bottom: 1px solid #e2e8f0;
            margin-bottom: 4px;
        }

        .pheno-toc-pill {
            display: inline-block;
            font-size: 0.78rem;
            padding: 3px 10px;
            border-radius: 12px;
            background: #dcfce7;
            color: #166534;
            text-decoration: none;
            cursor: pointer;
            white-space: nowrap;
            transition: background 0.15s;
        }

        .pheno-toc-pill:hover {
            background: #bbf7d0;
        }

        .pheno-toc-pill .pill-count {
            font-weight: 600;
            margin-left: 2px;
        }

        .pheno-toggle-all {
            font-size: 0.78rem;
            color: #16a34a;
            cursor: pointer;
            background: none;
            border: 1px solid #bbf7d0;
            border-radius: 6px;
            padding: 3px 10px;
            margin-left: auto;
            white-space: nowrap;
            transition: background 0.15s;
        }

        .pheno-toggle-all:hover {
            background: #f0fdf4;
        }

        /* Collapsible category groups */
        .phenotype-category-group {
            margin-bottom: 2px;
        }

        .phenotype-category-group summary {
            font-size: 0.85rem;
            font-weight: 600;
            text-transform: uppercase;
            letter-spacing: 0.04em;
            color: #16a34a;
            margin: 0;
            padding: 10px 0 6px 0;
            border-bottom: 1px solid #bbf7d0;
            cursor: pointer;
            list-style: none;
            display: flex;
            align-items: center;
            gap: 6px;
        }

        .phenotype-category-group summary::-webkit-details-marker {
            display: none;
        }

        .phenotype-category-group summary .chevron {
            display: inline-block;
            width: 16px;
            height: 16px;
            transition: transform 0.15s;
            flex-shrink: 0;
        }

        .phenotype-category-group[open] summary .chevron {
            transform: rotate(90deg);
        }

        .phenotype-category-group summary .cat-count {
            font-size: 0.75rem;
            font-weight: 400;
            color: #15803d;
            background: #dcfce7;
            padding: 1px 7px;
            border-radius: 8px;
        }

        /* Phenotype Contexts */
        .phenotype-contexts {
            margin-top: 10px;
        }

        .phenotype-contexts-toggle {
            font-size: 0.8rem;
            color: var(--text-muted);
            cursor: pointer;
            user-select: none;
        }

        .phenotype-contexts-toggle:hover {
            color: var(--primary);
        }

        .context-card {
            padding: 10px 14px;
            margin-top: 8px;
            border-radius: 8px;
            background: #ecfdf5;
            border: 1px solid #a7f3d0;
            font-size: 0.88rem;
        }

        .context-header {
            display: flex;
            flex-wrap: wrap;
            align-items: center;
            gap: 6px;
            margin-bottom: 6px;
        }

        .context-label {
            font-size: 0.72rem;
            font-weight: 600;
            text-transform: uppercase;
            letter-spacing: 0.04em;
            padding: 2px 8px;
            border-radius: 4px;
        }

        .context-label-genetic {
            background: #dbeafe;
            color: #1e40af;
        }

        .context-label-sex {
            background: #fce7f3;
            color: #9d174d;
        }

        .context-label-population {
            background: #fef3c7;
            color: #92400e;
        }

        .context-label-age {
            background: #e0e7ff;
            color: #3730a3;
        }

        .context-label-subtype {
            background: #ede9fe;
            color: #5b21b6;
        }

        .context-label-frequency {
            background: #dcfce7;
            color: #166534;
        }

        .context-gene-list {
            display: flex;
            flex-wrap: wrap;
            gap: 4px;
            margin: 4px 0;
        }

        .context-gene-tag {
            font-size: 0.78rem;
            font-weight: 600;
            padding: 1px 8px;
            border-radius: 4px;
            background: #bfdbfe;
            color: #1e3a8a;
        }

        .context-detail {
            font-size: 0.84rem;
            color: #065f46;
            line-height: 1.5;
        }

        .context-detail strong {
            color: #047857;
        }

        .context-freq {
            font-size: 0.75rem;
            padding: 2px 8px;
            border-radius: 10px;
            background: #bbf7d0;
            color: #14532d;
            font-weight: 600;
        }

        .context-onset {
            font-size: 0.75rem;
            padding: 2px 8px;
            border-radius: 10px;
            background: #e0e7ff;
            color: #3730a3;
        }

        .context-severity {
            font-size: 0.75rem;
            padding: 2px 8px;
            border-radius: 10px;
            background: #fef3c7;
            color: #92400e;
        }

        .context-notes {
            font-size: 0.84rem;
            color: #065f46;
            margin-top: 4px;
            line-height: 1.5;
        }

        /* Genetic */
        .genetic-box {
            background: #eff6ff;
            border-left: 4px solid #3b82f6;
        }
        .genetic-box .item-name { color: #1e40af; }
        .genetic-box .item-desc { color: #2563eb; }

        /* Treatment */
        .treatment-box {
            background: #faf5ff;
            border-left: 4px solid #8b5cf6;
        }
        .treatment-box .item-name { color: #5b21b6; }
        .treatment-box .item-desc { color: #7c3aed; }

        /* Environmental */
        .environmental-box {
            background: #f0fdfa;
            border-left: 4px solid #14b8a6;
        }
        .environmental-box .item-name { color: #0f766e; }
        .environmental-box .item-desc { color: #0d9488; }

        /* Biochemical */
        .biochemical-box {
            background: #fffbeb;
            border-left: 4px solid #f59e0b;
        }
        .biochemical-box .item-name { color: #92400e; }
        .biochemical-box .item-desc { color: #b45309; }

        /* Differential Diagnoses */
        .differential-box {
            background: #fef2f2;
            border-left: 4px solid #dc2626;
        }
        .differential-box .item-name { color: #7f1d1d; }
        .differential-box .item-desc { color: #b91c1c; }

        .differential-similarities {
            background: #fee2e2;
            border-left: 2px solid #dc2626;
            padding: 10px 12px;
            border-radius: 6px;
            margin: 8px 0;
            font-size: 0.9rem;
        }

        .differential-distinctions {
            background: #dcfce7;
            border-left: 2px solid #16a34a;
            padding: 10px 12px;
            border-radius: 6px;
            margin: 8px 0;
            font-size: 0.9rem;
        }

        .differential-similarities strong,
        .differential-distinctions strong {
            display: block;
            margin-bottom: 6px;
            font-size: 0.85rem;
            text-transform: uppercase;
            letter-spacing: 0.05em;
        }

        .differential-similarities ul,
        .differential-distinctions ul {
            margin-left: 16px;
            line-height: 1.6;
        }

        .differential-similarities li,
        .differential-distinctions li {
            margin: 4px 0;
            font-size: 0.9rem;
        }

        /* Datasets */
        .dataset-box {
            background: #f0f9ff;
            border-left: 4px solid #0284c7;
        }
        .dataset-box .item-name { color: #0c4a6e; }
        .dataset-box .item-desc { color: #0369a1; }

        .tag-dataset {
            background: #e0f2fe;
            color: #0369a1;
        }

        .tag-organism {
            background: #fae8ff;
            color: #a21caf;
        }

        .tag-datatype {
            background: #dbeafe;
            color: #1d4ed8;
        }

        /* Clinical Trials */
        .clinical-trial-box {
            background: #f5f3ff;
            border-left: 4px solid #a855f7;
        }
        .clinical-trial-box .item-name { color: #6b21a8; }
        .clinical-trial-box .item-desc { color: #7e22ce; }

        .tag-phase {
            background: #ede9fe;
            color: #6b21a8;
        }

        .tag-status {
            background: #fce7f3;
            color: #9d174d;
        }

        .trial-nct a {
            font-family: 'Fira Code', 'Consolas', monospace;
            font-size: 0.85rem;
            color: var(--secondary);
            text-decoration: none;
        }

        .trial-nct a:hover {
            text-decoration: underline;
        }

        .dataset-accession a {
            font-family: 'Fira Code', 'Consolas', monospace;
            font-size: 0.85rem;
            color: var(--secondary);
            text-decoration: none;
        }

        .dataset-accession a:hover {
            text-decoration: underline;
        }

        /* Subtypes */
        .subtype-box {
            background: #eef2ff;
            border-left: 4px solid var(--secondary);
        }
        .subtype-box .item-name { color: #3730a3; }
        .subtype-box .item-desc { color: #4f46e5; }
        .classification-header {
            font-size: 1rem;
            font-weight: 600;
            color: #4338ca;
            margin: 1.2rem 0 0.5rem 0;
            padding-bottom: 0.3rem;
            border-bottom: 2px solid #c7d2fe;
            text-transform: capitalize;
        }
        .subtype-meta {
            display: flex;
            flex-wrap: wrap;
            gap: 0.4rem;
            margin: 0.3rem 0;
        }
        .subtype-freq-badge {
            background: #dbeafe;
            color: #1e40af;
            padding: 0.15rem 0.5rem;
            border-radius: 9999px;
            font-size: 0.8rem;
            font-weight: 500;
        }
        .subtype-gene-tag {
            background: #fef3c7;
            color: #92400e;
            padding: 0.15rem 0.5rem;
            border-radius: 9999px;
            font-size: 0.8rem;
            font-weight: 500;
        }
        .subtype-inheritance-tag {
            background: #ede9fe;
            color: #5b21b6;
            padding: 0.15rem 0.5rem;
            border-radius: 9999px;
            font-size: 0.8rem;
            font-weight: 500;
        }
        .subtype-term-link {
            font-size: 0.8rem;
            color: #6366f1;
            text-decoration: none;
        }
        .subtype-term-link:hover { text-decoration: underline; }
        .subtype-children {
            margin: 0.4rem 0 0.2rem 1rem;
            padding: 0;
            list-style: none;
        }
        .subtype-children li {
            font-size: 0.85rem;
            color: #4338ca;
            padding: 0.1rem 0;
        }
        .subtype-children li::before {
            content: "‚Ü≥ ";
            color: #a5b4fc;
        }

        /* Stats bar */
        .stats-bar {
            display: flex;
            gap: 24px;
            padding: 20px 24px;
            background: var(--card-bg);
            border-radius: 12px;
            border: 1px solid var(--border);
            margin-bottom: 24px;
            flex-wrap: wrap;
        }

        .stat-item {
            text-align: center;
        }

        .stat-link {
            text-decoration: none;
            color: inherit;
        }

        .stat-value {
            font-size: 1.5rem;
            font-weight: 700;
            color: var(--primary);
        }

        .stat-label {
            font-size: 0.8rem;
            color: var(--text-muted);
            text-transform: uppercase;
            letter-spacing: 0.05em;
        }

        /* YAML preview */
        .yaml-preview {
            background: #1e293b;
            color: #e2e8f0;
            padding: 20px;
            border-radius: 8px;
            overflow-x: auto;
            font-family: 'Fira Code', 'Consolas', monospace;
            font-size: 0.85rem;
            line-height: 1.5;
            max-height: 400px;
            overflow-y: auto;
        }

        .yaml-content {
            display: none;
        }

        .yaml-content.show {
            display: block;
        }

        /* Footer */
        .page-footer {
            margin-top: 40px;
            padding-top: 20px;
            border-top: 1px solid var(--border);
            text-align: center;
            color: var(--text-muted);
            font-size: 0.85rem;
        }

        .page-footer a {
            color: var(--primary);
            text-decoration: none;
        }

        .page-footer a:hover {
            text-decoration: underline;
        }

        /* Responsive */
        @media (max-width: 768px) {
            .page-header h1 { font-size: 1.6rem; }
            .stats-bar { gap: 16px; }
            .section-grid { grid-template-columns: 1fr; }
        }
        /* Mermaid graph */
        .mermaid-container {
            text-align: center;
            margin: 20px 0;
            padding: 20px;
            background: white;
            border-radius: 8px;
            border: 1px solid var(--border);
            overflow-x: auto;
        }

        .mermaid svg {
            max-width: 100%;
            height: auto;
        }

        .graph-warning {
            background: #fef3c7;
            border: 1px solid #f59e0b;
            border-radius: 8px;
            padding: 12px 16px;
            margin-bottom: 16px;
            font-size: 0.85rem;
            color: #92400e;
        }

        .graph-warning strong {
            display: block;
            margin-bottom: 4px;
        }

        .graph-warning ul {
            margin: 8px 0 0 20px;
            padding: 0;
        }

        .graph-warning li {
            margin: 4px 0;
        }
    </style>
    <script src="https://cdn.jsdelivr.net/npm/mermaid@10/dist/mermaid.min.js"></script>
    <script>
        mermaid.initialize({
            startOnLoad: true,
            theme: 'default',
            flowchart: {
                htmlLabels: true,
                curve: 'basis'
            }
        });
    </script>
</head>
<body>
    <div class="notice-banner" role="button" tabindex="0">This resource is in its pre-alpha development stage. Content is actively being curated and may be incomplete or subject to change.</div>
    

    

    
    

    
    

    

    

    

    

    

    <div class="container">
        <nav class="breadcrumb">
            <a href="../../app/index.html">Browse All</a>
            <span> / </span>
            <span>Primary_Ciliary_Dyskinesia</span>
        </nav>

        <header class="page-header">
            <h1>Primary_Ciliary_Dyskinesia</h1>
            <div class="header-meta">
                
                <span class="badge badge-category">Genetic</span>
                
                
                <span class="badge badge-mondo">
                    <a href="http://purl.obolibrary.org/obo/MONDO_0016575" target="_blank">
                        MONDO:0016575
                    </a>
                </span>
                
                
                <span class="badge badge-category" style="background: rgba(255,255,255,0.1);">Ciliopathy</span>
                
                <span class="badge badge-category" style="background: rgba(255,255,255,0.1);">Respiratory Disease</span>
                
            </div>
            
        </header>

        <!-- Stats bar -->
        
        
        
        
        
        
        
        
        
        
        
        
        
        <div class="stats-bar">
            
            <div class="stat-item">
                <div class="stat-value">0</div>
                <div class="stat-label">Mappings</div>
            </div>
            
            
            <div class="stat-item">
                <div class="stat-value">0</div>
                <div class="stat-label">Definitions</div>
            </div>
            
            
            <div class="stat-item">
                <div class="stat-value">0</div>
                <div class="stat-label">Inheritance</div>
            </div>
            
            
            <a class="stat-link" href="#pathophysiology">
            <div class="stat-item">
                <div class="stat-value">3</div>
                <div class="stat-label">Pathophysiology</div>
            </div>
            </a>
            
            
            <div class="stat-item">
                <div class="stat-value">0</div>
                <div class="stat-label">Histopathology</div>
            </div>
            
            
            <a class="stat-link" href="#phenotypes">
            <div class="stat-item">
                <div class="stat-value">13</div>
                <div class="stat-label">Phenotypes</div>
            </div>
            </a>
            
            
            <a class="stat-link" href="#genetic">
            <div class="stat-item">
                <div class="stat-value">12</div>
                <div class="stat-label">Genes</div>
            </div>
            </a>
            
            
            <a class="stat-link" href="#treatments">
            <div class="stat-item">
                <div class="stat-value">6</div>
                <div class="stat-label">Treatments</div>
            </div>
            </a>
            
            
            <div class="stat-item">
                <div class="stat-value">0</div>
                <div class="stat-label">Subtypes</div>
            </div>
            
            
            <div class="stat-item">
                <div class="stat-value">0</div>
                <div class="stat-label">Differentials</div>
            </div>
            
            
            <div class="stat-item">
                <div class="stat-value">0</div>
                <div class="stat-label">Datasets</div>
            </div>
            
            
            <div class="stat-item">
                <div class="stat-value">0</div>
                <div class="stat-label">Trials</div>
            </div>
            
        </div>

        <!-- Classifications -->
        
        <div class="card">
            <div class="card-header">
                <div class="card-icon" style="background: #fef3c7; color: #d97706;">üè∑</div>
                <h2 class="card-title">Classifications</h2>
            </div>
            
            <div style="margin-bottom: 16px;">
                <div class="classification-category">Harrison's Chapter</div>
                <div class="tag-list">
                    
                    <span class="tag tag-classification">respiratory system disorder</span>
                    
                    <span class="tag tag-classification">hereditary disease</span>
                    
                </div>
            </div>
            
            
            <div style="margin-bottom: 16px;">
                <div class="classification-category">Mechanistic Nosology</div>
                <div class="tag-list">
                    
                    <span class="tag tag-mechanistic">ciliopathy</span>
                    
                </div>
            </div>
            
            
            
            
            
        </div>
        

        <!-- Mappings -->
        

        <!-- Definitions -->
        

        <!-- Inheritance -->
        

        <!-- Subtypes -->
        

        <!-- Comorbidities -->
        

        <!-- Pathophysiology -->
        
        <div class="card" id="pathophysiology">
            <div class="card-header">
                <div class="card-icon" style="background: #fef3c7; color: #d97706;">‚öô</div>
                <h2 class="card-title">Pathophysiology</h2>
                <span class="card-count">3</span>
            </div>
            
            <div class="item-box pathophys-box">
                <div class="item-name">Ciliary Dysfunction</div>
                
                <div class="item-desc">Defects in the structure and function of motile cilia impair mucociliary clearance.</div>
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-cell">
                        respiratory ciliated cell
                        
                        <a href="http://purl.obolibrary.org/obo/CL_0002368" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                    <span class="tag tag-cell">
                        ependymal cell
                        
                        <a href="http://purl.obolibrary.org/obo/CL_0000065" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                </div>
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-gene">
                        DNAI1
                        
                        <a href="https://bioregistry.io/hgnc:2954" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
                    <span class="tag tag-gene">
                        DNAH5
                        
                        <a href="https://bioregistry.io/hgnc:2950" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
                </div>
                
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-bio">
                        cilium movement
                        
                        <a href="http://purl.obolibrary.org/obo/GO_0003341" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                    <span class="tag tag-bio">
                        cilium assembly
                        
                        <a href="http://purl.obolibrary.org/obo/GO_0060271" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                    <span class="tag tag-bio">
                        axoneme assembly
                        
                        <a href="http://purl.obolibrary.org/obo/GO_0035082" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                </div>
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-component">
                        Cilia
                        
                        <a href="http://purl.obolibrary.org/obo/GO_0005929" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
                    <span class="tag tag-component">
                        axoneme
                        
                        <a href="http://purl.obolibrary.org/obo/GO_0005930" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
                    <span class="tag tag-component">
                        outer dynein arm
                        
                        <a href="http://purl.obolibrary.org/obo/GO_0036157" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
                </div>
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-location">
                        respiratory tract epithelium
                        
                        <a href="http://purl.obolibrary.org/obo/UBERON_0004808" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
                    <span class="tag tag-location">
                        nasal cavity epithelium
                        
                        <a href="http://purl.obolibrary.org/obo/UBERON_0000398" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
                    <span class="tag tag-location">
                        trachea
                        
                        <a href="http://purl.obolibrary.org/obo/UBERON_0003126" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
                    <span class="tag tag-location">
                        bronchus
                        
                        <a href="http://purl.obolibrary.org/obo/UBERON_0002185" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
                </div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (5 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/19818430" target="_blank">PMID:19818430</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Primary ciliary dyskinesia is a genetically inherited syndrome characterized by cilia immotility or dysmotility. Deficiency in mucociliary clearance produces chronic respiratory infections since birth."</div>
                
                
                <div class="evidence-explanation">The reference confirms that defects in the structure and function of motile cilia impair mucociliary clearance, supporting the statement.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/20525503" target="_blank">PMID:20525503</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Ciliary dysfunction may be primary, the result of genetic mutations resulting in abnormal cilia structure, or secondary, the result of environmental, infectious or inflammatory stimuli that disrupt normal motility or coordination."</div>
                
                
                <div class="evidence-explanation">This reference supports the statement by indicating that primary ciliary dyskinesia results from genetic mutations affecting cilia structure and function, leading to impaired mucociliary clearance.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/17059358" target="_blank">PMID:17059358</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"The most prominent genetic abnormality involving motile cilia (and the respiratory tract) is primary ciliary dyskinesia (PCD). PCD is a rare, usually autosomal recessive, genetically heterogeneous disorder characterized by sino-pulmonary disease, laterality defects, and male infertility."</div>
                
                
                <div class="evidence-explanation">The reference supports the statement by describing PCD as a disorder involving motile cilia defects, which leads to respiratory issues due to impaired mucociliary clearance.</div>
                
            </div>
            
            
            <div class="evidence-more">+ 2 more references</div>
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box pathophys-box">
                <div class="item-name">Impaired Mucociliary Clearance</div>
                
                <div class="item-desc">Failure to effectively remove mucus and pathogens from respiratory passages.</div>
                
                
                
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-bio">
                        mucociliary clearance
                        
                        <a href="http://purl.obolibrary.org/obo/GO_0120197" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                </div>
                
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-location">
                        respiratory system
                        
                        <a href="http://purl.obolibrary.org/obo/UBERON_0001004" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
                    <span class="tag tag-location">
                        paranasal sinus
                        
                        <a href="http://purl.obolibrary.org/obo/UBERON_0001825" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
                </div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (4 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/11376511" target="_blank">PMID:11376511</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Failure to keep the airways sterile by MCC results in a host inflammatory response to the persistent microorganisms which, if it becomes chronic, causes damage to the airway wall and upregulation of mucus production manifest clinically as bronchiectasis, sinusitis and otitis."</div>
                
                
                <div class="evidence-explanation">The literature supports that primary ciliary dyskinesia (PCD) leads to impaired mucociliary clearance, which results in chronic respiratory infections, sinusitis, and otitis media.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/17142159" target="_blank">PMID:17142159</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Primary ciliary dyskinesia is an autosomal recessive genetic disease that results in impaired mucociliary clearance causing progressive involvement of the upper and lower respiratory tract, characterized by airway obstruction and recurrent infections of the lungs, middle ear and paranasal sinuses."</div>
                
                
                <div class="evidence-explanation">The literature supports that primary ciliary dyskinesia leads to impaired mucociliary clearance and downstream chronic respiratory infections, sinusitis, and otitis media.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/15917207" target="_blank">PMID:15917207</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Disruption of 9+2 cilia, which move mucus across respiratory epithelia, leads to rhinitis, sinusitis and bronchiectasis."</div>
                
                
                <div class="evidence-explanation">The literature supports that disruption of motile cilia, as seen in primary ciliary dyskinesia, leads to impaired mucociliary clearance and resultant respiratory conditions such as sinusitis and bronchiectasis.</div>
                
            </div>
            
            
            <div class="evidence-more">+ 1 more reference</div>
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box pathophys-box">
                <div class="item-name">Situs Inversus</div>
                
                <div class="item-desc">Abnormal placement of internal organs due to ciliary dysfunction during embryonic development.</div>
                
                
                
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-bio">
                        determination of left/right symmetry
                        
                        <a href="http://purl.obolibrary.org/obo/GO_0007368" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                    <span class="tag tag-bio">
                        nodal cilium assembly
                        
                        <a href="http://purl.obolibrary.org/obo/GO_1904955" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                </div>
                
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-location">
                        embryo
                        
                        <a href="http://purl.obolibrary.org/obo/UBERON_0000922" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
                </div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (2 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/16036877" target="_blank">PMID:16036877</a>
                    </span>
                    
                    <span class="evidence-support support-PARTIAL">PARTIAL</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"The normal left-right asymmetry of the body is thought to be due to the beating of the cilia in the embryonic (Hensen&#39;s) node. Total immotility of the cilia should therefore result in random asymmetry of the body that is situs inversus in 50% of the cases. It has also been claimed that 50% of..."</div>
                
                
                <div class="evidence-explanation">The statement is partially supported. The literature confirms that primary ciliary dyskinesia (PCD) can lead to situs inversus due to ciliary dysfunction during embryonic development, and it is claimed that 50% of PCD cases have situs inversus. However, the phrase &#39;abnormal placement of internal organs&#39; is more general and could include other forms of laterality defects, not just situs inversus.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/36342963" target="_blank">PMID:36342963</a>
                    </span>
                    
                    <span class="evidence-support support-PARTIAL">PARTIAL</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Results: Of 559 participants, 286 (51.2%), 215 (38.5%), and 58 (10.4%) were identified as having situs solitus, situs inversustotalis, and situs ambiguus, respectively; heterotaxy, defined as situs ambiguus with complex cardiovascular defects, was present in 14 (2.5%)"</div>
                
                
                <div class="evidence-explanation">The statement is partially supported. The data shows that 38.5% of PCD cases have situs inversus totalis, which is close to but not exactly 50%. Additionally, there are other laterality defects like situs ambiguus, which are not covered by the statement.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
        </div>
        

        <!-- Histopathology -->
        

        <!-- Causal Graph -->
        
        <div class="card">
            <div class="card-header">
                <div class="card-icon" style="background: #e0e7ff; color: #4f46e5;">‚¨°</div>
                <h2 class="card-title">Causal Graph</h2>
            </div>
            
            <div class="mermaid-container">
                <pre class="mermaid">graph LR
    Ciliary_Dysfunction[&#34;Ciliary Dysfunction&#34;]
    Chronic_Respiratory_Infections[&#34;Chronic Respiratory Infections&#34;]
    Sinusitis[&#34;Sinusitis&#34;]
    Impaired_Mucociliary_Clearance[&#34;Impaired Mucociliary Clearance&#34;]
    Otitis_Media[&#34;Otitis Media&#34;]

    Ciliary_Dysfunction --&gt; Impaired_Mucociliary_Clearance
    Impaired_Mucociliary_Clearance --&gt; Chronic_Respiratory_Infections
    Impaired_Mucociliary_Clearance --&gt; Sinusitis
    Impaired_Mucociliary_Clearance --&gt; Otitis_Media

    style Ciliary_Dysfunction fill:#dbeafe
    style Chronic_Respiratory_Infections fill:#fef3c7
    style Sinusitis fill:#fef3c7
    style Impaired_Mucociliary_Clearance fill:#dbeafe
    style Otitis_Media fill:#fef3c7</pre>
            </div>
        </div>
        

        <!-- Phenotypes -->
        
        <div class="card" id="phenotypes">
            <div class="card-header">
                <div class="card-icon" style="background: #dcfce7; color: #16a34a;">‚óè</div>
                <h2 class="card-title">Phenotypes</h2>
                <span class="card-count">13</span>
            </div>
            
            
            <div class="pheno-toc">
                
                <a class="pheno-toc-pill" data-target="pheno-cat-1">Cardiovascular<span class="pill-count">(1)</span></a>
                
                <a class="pheno-toc-pill" data-target="pheno-cat-2">Ear<span class="pill-count">(3)</span></a>
                
                <a class="pheno-toc-pill" data-target="pheno-cat-3">Genitourinary<span class="pill-count">(1)</span></a>
                
                <a class="pheno-toc-pill" data-target="pheno-cat-4">Head and Neck<span class="pill-count">(2)</span></a>
                
                <a class="pheno-toc-pill" data-target="pheno-cat-5">Immune<span class="pill-count">(2)</span></a>
                
                <a class="pheno-toc-pill" data-target="pheno-cat-6">Respiratory<span class="pill-count">(3)</span></a>
                
                <a class="pheno-toc-pill" data-target="pheno-cat-7">Other<span class="pill-count">(1)</span></a>
                
                <button class="pheno-toggle-all" id="phenoToggleAll">Expand all</button>
            </div>
            
            
            <details class="phenotype-category-group" id="pheno-cat-1">
                <summary>
                    <svg class="chevron" viewBox="0 0 16 16" fill="currentColor"><path d="M6 3l5 5-5 5V3z"/></svg>
                    Cardiovascular
                    <span class="cat-count">1</span>
                </summary>
                
                <div class="item-box phenotype-box">
                    <div class="item-name">
                        Situs Inversus Totalis
                        
                        <span class="phenotype-freq">OCCASIONAL</span>
                        
                        
                        <span class="phenotype-id">
                            <a href="http://purl.obolibrary.org/obo/HP_0001696" target="_blank">
                                Situs inversus totalis
                            </a>
                            <span style="font-size: 0.72rem; color: var(--text-muted);">(HP:0001696)</span>
                        </span>
                        
                    </div>
                    
                    
                    
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (3 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/16036877" target="_blank">PMID:16036877</a>
                    </span>
                    
                    <span class="evidence-support support-PARTIAL">PARTIAL</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Total immotility of the cilia should therefore result in random asymmetry of the body that is situs inversus in 50% of the cases. It has also been claimed that 50% of cases with PCD have situs inversus."</div>
                
                
                <div class="evidence-explanation">The literature indicates that situs inversus, including situs inversus totalis, occurs in approximately 50% of primary ciliary dyskinesia (PCD) cases. This suggests that it is not merely &#39;occasional&#39; but rather relatively common in PCD patients.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/36342963" target="_blank">PMID:36342963</a>
                    </span>
                    
                    <span class="evidence-support support-PARTIAL">PARTIAL</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Results: Of 559 participants, 286 (51.2%), 215 (38.5%), and 58 (10.4%) were identified as having situs solitus, situs inversustotalis, and situs ambiguus, respectively; heterotaxy, defined as situs ambiguus with complex cardiovascular defects, was present in 14 (2.5%)"</div>
                
                
                <div class="evidence-explanation">The data indicates that situs inversus totalis occurs in 38.5% of PCD cases, which is more frequent than &#39;occasional.&#39;</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/38072392" target="_blank">PMID:38072392</a>
                    </span>
                    
                    <span class="evidence-support support-PARTIAL">PARTIAL</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"The remaining 355 participants did not have SA, including 152 with SIT and 203 with SS."</div>
                
                
                <div class="evidence-explanation">Situs inversus totalis (SIT) is present in a significant portion of PCD cases, indicating it is more common than &#39;occasional.&#39;</div>
                
            </div>
            
            
        </div>
    </details>
    
    
                    
    
    
                </div>
                
            </details>
            
            <details class="phenotype-category-group" id="pheno-cat-2">
                <summary>
                    <svg class="chevron" viewBox="0 0 16 16" fill="currentColor"><path d="M6 3l5 5-5 5V3z"/></svg>
                    Ear
                    <span class="cat-count">3</span>
                </summary>
                
                <div class="item-box phenotype-box">
                    <div class="item-name">
                        Chronic Otitis Media
                        
                        <span class="phenotype-freq">FREQUENT</span>
                        
                        
                        <span class="phenotype-id">
                            <a href="http://purl.obolibrary.org/obo/HP_0000389" target="_blank">
                                Chronic otitis media
                            </a>
                            <span style="font-size: 0.72rem; color: var(--text-muted);">(HP:0000389)</span>
                        </span>
                        
                    </div>
                    
                    
                    
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (2 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/29135867" target="_blank">PMID:29135867</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"All 15 patients showed ciliary ultrastructural abnormalities on electron microscopy and/or biallelic mutations in genes associated with ciliary function or structure. All 30 eardrums examined showed certain abnormalities. Fourteen patients had otitis media with effusion or its sequelae. The..."</div>
                
                
                <div class="evidence-explanation">The study found that patients with primary ciliary dyskinesia (PCD) frequently exhibited otologic issues, including chronic otitis media.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/19796826" target="_blank">PMID:19796826</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Primary ciliary dyskinesia is an autosomal recessively inherited group of disorders of ciliary ultrastructure. Otolaryngologists are frequently involved in the management of some of the most common symptoms of primary ciliary dyskinesia including chronic rhinitis, sinusitis and otitis media with..."</div>
                
                
                <div class="evidence-explanation">This reference supports that chronic otitis media and other otologic issues are common in patients with primary ciliary dyskinesia.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
                    
    
    
                </div>
                
                <div class="item-box phenotype-box">
                    <div class="item-name">
                        Hearing Loss
                        
                        <span class="phenotype-freq">OCCASIONAL</span>
                        
                        
                        <span class="phenotype-id">
                            <a href="http://purl.obolibrary.org/obo/HP_0000365" target="_blank">
                                Hearing impairment
                            </a>
                            <span style="font-size: 0.72rem; color: var(--text-muted);">(HP:0000365)</span>
                        </span>
                        
                    </div>
                    
                    
                    
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (3 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/29287859" target="_blank">PMID:29287859</a>
                    </span>
                    
                    <span class="evidence-support support-REFUTE">REFUTE</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Slight to mild CHL and all types of otitis media are prevalent among patients with PCD, and some of these children have sensorineural hearing loss (SNHL)."</div>
                
                
                <div class="evidence-explanation">The study indicates that hearing loss is a prevalent condition among patients with primary ciliary dyskinesia (PCD), not occasional.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/9222635" target="_blank">PMID:9222635</a>
                    </span>
                    
                    <span class="evidence-support support-REFUTE">REFUTE</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"All children (11 patients) had bilateral otitis media with effusion. Of the five adults, three had tympanosclerosis; one had bilateral cholesteatoma; and one patient had bilateral keratosis obturans in combination with tympanosclerosis."</div>
                
                
                <div class="evidence-explanation">The study describes otological manifestations including hearing loss as a prominent feature in patients with PCD, suggesting it is not occasional but rather common.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/33844744" target="_blank">PMID:33844744</a>
                    </span>
                    
                    <span class="evidence-support support-NO_EVIDENCE">NO_EVIDENCE</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"In this group of patients with OI, 30% had hearing loss and among those ears with normal hearing, 13% did not have an acoustic stapedial reflex."</div>
                
                
                <div class="evidence-explanation">This study discusses hearing loss in osteogenesis imperfecta (OI), not primary ciliary dyskinesia (PCD).</div>
                
            </div>
            
            
        </div>
    </details>
    
    
                    
    
    
                </div>
                
                <div class="item-box phenotype-box">
                    <div class="item-name">
                        Otitis Media
                        
                        <span class="phenotype-freq">FREQUENT</span>
                        
                        
                        <span class="phenotype-id">
                            <a href="http://purl.obolibrary.org/obo/HP_0000388" target="_blank">
                                Otitis media
                            </a>
                            <span style="font-size: 0.72rem; color: var(--text-muted);">(HP:0000388)</span>
                        </span>
                        
                    </div>
                    
                    
                    
    
    
                    
    
    
                </div>
                
            </details>
            
            <details class="phenotype-category-group" id="pheno-cat-3">
                <summary>
                    <svg class="chevron" viewBox="0 0 16 16" fill="currentColor"><path d="M6 3l5 5-5 5V3z"/></svg>
                    Genitourinary
                    <span class="cat-count">1</span>
                </summary>
                
                <div class="item-box phenotype-box">
                    <div class="item-name">
                        Male Infertility
                        
                        <span class="phenotype-freq">FREQUENT</span>
                        
                        
                        <span class="phenotype-id">
                            <a href="http://purl.obolibrary.org/obo/HP_0003251" target="_blank">
                                Male infertility
                            </a>
                            <span style="font-size: 0.72rem; color: var(--text-muted);">(HP:0003251)</span>
                        </span>
                        
                    </div>
                    
                    <div class="item-desc">Due to sperm flagellar defects affecting motility</div>
                    
                    
                    
    
    
                    
    
    
                </div>
                
            </details>
            
            <details class="phenotype-category-group" id="pheno-cat-4">
                <summary>
                    <svg class="chevron" viewBox="0 0 16 16" fill="currentColor"><path d="M6 3l5 5-5 5V3z"/></svg>
                    Head and Neck
                    <span class="cat-count">2</span>
                </summary>
                
                <div class="item-box phenotype-box">
                    <div class="item-name">
                        Sinusitis
                        
                        <span class="phenotype-freq">FREQUENT</span>
                        
                        
                        <span class="phenotype-id">
                            <a href="http://purl.obolibrary.org/obo/HP_0000246" target="_blank">
                                Sinusitis
                            </a>
                            <span style="font-size: 0.72rem; color: var(--text-muted);">(HP:0000246)</span>
                        </span>
                        
                    </div>
                    
                    
                    
    
    
                    
    
    
                </div>
                
                <div class="item-box phenotype-box">
                    <div class="item-name">
                        Chronic Rhinosinusitis
                        
                        <span class="phenotype-freq">VERY_FREQUENT</span>
                        
                        
                        <span class="phenotype-id">
                            <a href="http://purl.obolibrary.org/obo/HP_0011109" target="_blank">
                                Chronic sinusitis
                            </a>
                            <span style="font-size: 0.72rem; color: var(--text-muted);">(HP:0011109)</span>
                        </span>
                        
                    </div>
                    
                    <div class="item-desc">Chronic inflammation of nasal passages and sinuses</div>
                    
                    
                    
    
    
                    
    
    
                </div>
                
            </details>
            
            <details class="phenotype-category-group" id="pheno-cat-5">
                <summary>
                    <svg class="chevron" viewBox="0 0 16 16" fill="currentColor"><path d="M6 3l5 5-5 5V3z"/></svg>
                    Immune
                    <span class="cat-count">2</span>
                </summary>
                
                <div class="item-box phenotype-box">
                    <div class="item-name">
                        Recurrent Respiratory Infections
                        
                        <span class="phenotype-freq">VERY_FREQUENT</span>
                        
                        
                        <span class="phenotype-id">
                            <a href="http://purl.obolibrary.org/obo/HP_0002205" target="_blank">
                                Recurrent respiratory infections
                            </a>
                            <span style="font-size: 0.72rem; color: var(--text-muted);">(HP:0002205)</span>
                        </span>
                        
                    </div>
                    
                    
                    
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (4 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/39069333" target="_blank">PMID:39069333</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"This review article explores the respiratory aspects of primary ciliary dyskinesia (PCD), a rare, heterogenous, genetic disorder characterized by impaired motile ciliary function. It discusses the clinical diagnosis and management strategies for PCD-related respiratory disease, including chronic..."</div>
                
                
                <div class="evidence-explanation">The article discusses recurrent respiratory diseases as a significant aspect of PCD, supporting the statement that recurrent respiratory infections are very frequent in PCD.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/36214320" target="_blank">PMID:36214320</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Ninety-two children with chronic respiratory symptoms were divided into 4 groups: 18 children with refractory asthma, 10 with bronchiectasis without dextrocardia, 18 with dextrocardia and 46 with recurrent respiratory tract infections."</div>
                
                
                <div class="evidence-explanation">The study highlights recurrent respiratory tract infections in children with chronic respiratory symptoms, supporting the statement that recurrent respiratory infections are very frequent in PCD.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/31430425" target="_blank">PMID:31430425</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"The objective of this study was to evaluate the prevalence of chronic rhinosinusitis (CRS) and its characteristics in bronchiectasis patients suspected of harboring ciliary dyskinesia."</div>
                
                
                <div class="evidence-explanation">The study mentions chronic rhinosinusitis and bronchiectasis in patients suspected of ciliary dyskinesia, indicating frequent respiratory issues.</div>
                
            </div>
            
            
            <div class="evidence-more">+ 1 more reference</div>
            
        </div>
    </details>
    
    
                    
    
    
                </div>
                
                <div class="item-box phenotype-box">
                    <div class="item-name">
                        Chronic Respiratory Infections
                        
                        <span class="phenotype-freq">FREQUENT</span>
                        
                        
                        <span class="phenotype-id">
                            <a href="http://purl.obolibrary.org/obo/HP_0002205" target="_blank">
                                Recurrent respiratory infections
                            </a>
                            <span style="font-size: 0.72rem; color: var(--text-muted);">(HP:0002205)</span>
                        </span>
                        
                    </div>
                    
                    
                    
    
    
                    
    
    
                </div>
                
            </details>
            
            <details class="phenotype-category-group" id="pheno-cat-6">
                <summary>
                    <svg class="chevron" viewBox="0 0 16 16" fill="currentColor"><path d="M6 3l5 5-5 5V3z"/></svg>
                    Respiratory
                    <span class="cat-count">3</span>
                </summary>
                
                <div class="item-box phenotype-box">
                    <div class="item-name">
                        Chronic Cough
                        
                        <span class="phenotype-freq">VERY_FREQUENT</span>
                        
                        
                        <span class="phenotype-id">
                            <a href="http://purl.obolibrary.org/obo/HP_0034315" target="_blank">
                                Chronic cough
                            </a>
                            <span style="font-size: 0.72rem; color: var(--text-muted);">(HP:0034315)</span>
                        </span>
                        
                    </div>
                    
                    
                    
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (2 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/27258773" target="_blank">PMID:27258773</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Primary ciliary dyskinesia (PCD) is a rare, heterogeneous, recessive, genetic disorder of motile cilia, leading to chronic upper and lower respiratory symptoms."</div>
                
                
                <div class="evidence-explanation">The statement is supported because PCD leads to chronic respiratory symptoms, including chronic cough.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/17142159" target="_blank">PMID:17142159</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Primary ciliary dyskinesia is an autosomal recessive genetic disease that results in impaired mucociliary clearance causing progressive involvement of the upper and lower respiratory tract, characterized by airway obstruction and recurrent infections of the lungs, middle ear and paranasal sinuses."</div>
                
                
                <div class="evidence-explanation">The statement is supported because PCD causes progressive involvement of the respiratory tract, which includes chronic cough.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
                    
    
    
                </div>
                
                <div class="item-box phenotype-box">
                    <div class="item-name">
                        Bronchiectasis
                        
                        <span class="phenotype-freq">FREQUENT</span>
                        
                        
                        <span class="phenotype-id">
                            <a href="http://purl.obolibrary.org/obo/HP_0002110" target="_blank">
                                Bronchiectasis
                            </a>
                            <span style="font-size: 0.72rem; color: var(--text-muted);">(HP:0002110)</span>
                        </span>
                        
                    </div>
                    
                    
                    
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (9 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/10894096" target="_blank">PMID:10894096</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Patients with primary ciliary dyskinesia could potentially develop recurrent sinotrachrobronchitis, bronchiectasis, serous otitis media, hydrocephalus, and male infertility."</div>
                
                
                <div class="evidence-explanation">The article mentions bronchiectasis as one of the potential conditions that patients with PCD could develop.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/36344229" target="_blank">PMID:36344229</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Typical manifestations include bronchiectasis, secretory otitis media, sinusitis, situs inversus, and infertility."</div>
                
                
                <div class="evidence-explanation">The article lists bronchiectasis as a typical manifestation of primary ciliary dyskinesia.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/25673230" target="_blank">PMID:25673230</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Primary ciliary dyskinesia (PCD) is a rare disease, characterised by chronic airway infection."</div>
                
                
                <div class="evidence-explanation">The article discusses the relationship between functional and structural abnormalities in PCD, including bronchiectasis.</div>
                
            </div>
            
            
            <div class="evidence-more">+ 6 more references</div>
            
        </div>
    </details>
    
    
                    
    
    
                </div>
                
                <div class="item-box phenotype-box">
                    <div class="item-name">
                        Neonatal Respiratory Distress
                        
                        <span class="phenotype-freq">FREQUENT</span>
                        
                        
                        <span class="phenotype-id">
                            <a href="http://purl.obolibrary.org/obo/HP_0002643" target="_blank">
                                Neonatal respiratory distress
                            </a>
                            <span style="font-size: 0.72rem; color: var(--text-muted);">(HP:0002643)</span>
                        </span>
                        
                    </div>
                    
                    <div class="item-desc">Common presenting feature in newborns with PCD</div>
                    
                    
                    
    
    
                    
    
    
                </div>
                
            </details>
            
            <details class="phenotype-category-group" id="pheno-cat-7">
                <summary>
                    <svg class="chevron" viewBox="0 0 16 16" fill="currentColor"><path d="M6 3l5 5-5 5V3z"/></svg>
                    Other
                    <span class="cat-count">1</span>
                </summary>
                
                <div class="item-box phenotype-box">
                    <div class="item-name">
                        Nasal Polyps
                        
                        <span class="phenotype-freq">FREQUENT</span>
                        
                        
                    </div>
                    
                    
                    
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (2 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/37997295" target="_blank">PMID:37997295</a>
                    </span>
                    
                    <span class="evidence-support support-NO_EVIDENCE">NO_EVIDENCE</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Despite endoscopic differences, PCD-CRS and cystic fibrosis-related chronic rhinosinusitis (CF-CRS) had similar structured histopathology reports. Compared to healthy patients and those with idiopathic chronic rhinosinusitis without nasal polyps, patients with PCD-CRS had an increased neutrophil count."</div>
                
                
                <div class="evidence-explanation">The abstract discusses histopathology and neutrophil count in PCD-CRS, but does not provide evidence on the frequency of nasal polyps in PCD.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/39069333" target="_blank">PMID:39069333</a>
                    </span>
                    
                    <span class="evidence-support support-NO_EVIDENCE">NO_EVIDENCE</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"This review article explores the respiratory aspects of primary ciliary dyskinesia (PCD), a rare, heterogenous, genetic disorder characterized by impaired motile ciliary function. It discusses the clinical diagnosis and management strategies for PCD-related respiratory disease, including chronic..."</div>
                
                
                <div class="evidence-explanation">The review focuses on respiratory aspects of PCD and does not mention nasal polyps as a frequent gastrointestinal manifestation.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
                    
    
    
                </div>
                
            </details>
            
            <script>
            (function() {
                // TOC pill click: expand target group and scroll to it
                document.querySelectorAll('.pheno-toc-pill').forEach(function(pill) {
                    pill.addEventListener('click', function() {
                        var target = document.getElementById(pill.dataset.target);
                        if (target) {
                            target.open = true;
                            target.scrollIntoView({behavior: 'smooth', block: 'start'});
                        }
                    });
                });
                // Expand/collapse all toggle
                var btn = document.getElementById('phenoToggleAll');
                if (btn) {
                    btn.addEventListener('click', function() {
                        var groups = document.querySelectorAll('.phenotype-category-group');
                        var anyOpen = Array.from(groups).some(function(g) { return g.open; });
                        groups.forEach(function(g) { g.open = !anyOpen; });
                        btn.textContent = anyOpen ? 'Expand all' : 'Collapse all';
                    });
                }
            })();
            </script>
            
        </div>
        

        <!-- Genetic Associations -->
        
        <div class="card" id="genetic">
            <div class="card-header">
                <div class="card-icon" style="background: #dbeafe; color: #2563eb;">üß¨</div>
                <h2 class="card-title">Genetic Associations</h2>
                <span class="card-count">12</span>
            </div>
            
            <div class="item-box genetic-box">
                <div class="item-name">
                    DNAI1
                    
                    <span style="font-size: 0.8rem; font-weight: normal; opacity: 0.8;">(Pathogenic Variants)</span>
                    
                </div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (4 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/11893720" target="_blank">PMID:11893720</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Mutations in DNAI1 (IC78) cause primary ciliary dyskinesia."</div>
                
                
                <div class="evidence-explanation">This study directly links mutations in DNAI1 to the cause of primary ciliary dyskinesia.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/35869935" target="_blank">PMID:35869935</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"13 rare variants were identified in patients with PCD, among which were three homozygous causative variants (including one splicing variant) in the PCD-associated genes CCDC40 and DNAI1."</div>
                
                
                <div class="evidence-explanation">The study identifies causative variants in DNAI1 associated with primary ciliary dyskinesia.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/15750039" target="_blank">PMID:15750039</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"The most frequent genetic defects comprise recessive mutations of DNAH5 and DNAI1, which encode outer dynein arm (ODA) components."</div>
                
                
                <div class="evidence-explanation">This study mentions DNAI1 mutations as frequent genetic defects causing primary ciliary dyskinesia.</div>
                
            </div>
            
            
            <div class="evidence-more">+ 1 more reference</div>
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box genetic-box">
                <div class="item-name">
                    DNAH5
                    
                    <span style="font-size: 0.8rem; font-weight: normal; opacity: 0.8;">(Pathogenic Variants)</span>
                    
                </div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (2 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/31118369" target="_blank">PMID:31118369</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"A genetic examination detected compound heterozygous mutations of DNAH5 that encode ODA components."</div>
                
                
                <div class="evidence-explanation">The study reports a case of primary ciliary dyskinesia (PCD) with DNAH5 mutations, confirming the association between PCD and pathogenic variants in DNAH5.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/36727596" target="_blank">PMID:36727596</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Most PCD-causing variants result in abnormal outer dynein arms (ODAs), which provide the generative force for respiratory ciliary beating and proper mucociliary clearance."</div>
                
                
                <div class="evidence-explanation">The study indicates that pathogenic variants causing PCD often result in abnormal ODAs, which are associated with DNAH5.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box genetic-box">
                <div class="item-name">
                    DNAH11
                    
                    <span style="font-size: 0.8rem; font-weight: normal; opacity: 0.8;">(Pathogenic Variants)</span>
                    
                </div>
                
                
    
    
            </div>
            
            <div class="item-box genetic-box">
                <div class="item-name">
                    CCDC39
                    
                    <span style="font-size: 0.8rem; font-weight: normal; opacity: 0.8;">(Pathogenic Variants)</span>
                    
                </div>
                
                
    
    
            </div>
            
            <div class="item-box genetic-box">
                <div class="item-name">
                    CCDC40
                    
                    <span style="font-size: 0.8rem; font-weight: normal; opacity: 0.8;">(Pathogenic Variants)</span>
                    
                </div>
                
                
    
    
            </div>
            
            <div class="item-box genetic-box">
                <div class="item-name">
                    RSPH1
                    
                    <span style="font-size: 0.8rem; font-weight: normal; opacity: 0.8;">(Pathogenic Variants)</span>
                    
                </div>
                
                
    
    
            </div>
            
            <div class="item-box genetic-box">
                <div class="item-name">
                    RSPH4A
                    
                    <span style="font-size: 0.8rem; font-weight: normal; opacity: 0.8;">(Pathogenic Variants)</span>
                    
                </div>
                
                
    
    
            </div>
            
            <div class="item-box genetic-box">
                <div class="item-name">
                    RSPH9
                    
                    <span style="font-size: 0.8rem; font-weight: normal; opacity: 0.8;">(Pathogenic Variants)</span>
                    
                </div>
                
                
    
    
            </div>
            
            <div class="item-box genetic-box">
                <div class="item-name">
                    CCNO
                    
                    <span style="font-size: 0.8rem; font-weight: normal; opacity: 0.8;">(Pathogenic Variants)</span>
                    
                </div>
                
                
    
    
            </div>
            
            <div class="item-box genetic-box">
                <div class="item-name">
                    FOXJ1
                    
                    <span style="font-size: 0.8rem; font-weight: normal; opacity: 0.8;">(Pathogenic Variants)</span>
                    
                </div>
                
                
    
    
            </div>
            
            <div class="item-box genetic-box">
                <div class="item-name">
                    MCIDAS
                    
                    <span style="font-size: 0.8rem; font-weight: normal; opacity: 0.8;">(Pathogenic Variants)</span>
                    
                </div>
                
                
    
    
            </div>
            
            <div class="item-box genetic-box">
                <div class="item-name">
                    ODAD1
                    
                    <span style="font-size: 0.8rem; font-weight: normal; opacity: 0.8;">(Pathogenic Variants)</span>
                    
                </div>
                
                
    
    
            </div>
            
        </div>
        

        <!-- Treatments -->
        
        <div class="card" id="treatments">
            <div class="card-header">
                <div class="card-icon" style="background: #ede9fe; color: #7c3aed;">üíä</div>
                <h2 class="card-title">Treatments</h2>
                <span class="card-count">6</span>
            </div>
            
            <div class="item-box treatment-box">
                <div class="item-name">
                    Airway Clearance Techniques
                    
                    <span class="phenotype-id">
                        <a href="https://bioregistry.io/MAXO:0000011" target="_blank">
                            MAXO:0000011
                        </a>
                    </span>
                    
                </div>
                
                
                <div class="item-desc">Methods to help clear mucus from the lungs, such as chest physical therapy.</div>
                
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (3 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/28408202" target="_blank">PMID:28408202</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Airway clearance techniques (ACTs) are commonly recommended for patients with PCD to facilitate mucus clearance, despite a lack of evidence in this group."</div>
                
                
                <div class="evidence-explanation">The reference acknowledges the use of airway clearance techniques in patients with Primary Ciliary Dyskinesia (PCD) to help clear mucus from the lungs.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/38861625" target="_blank">PMID:38861625</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Airway clearance techniques (ACTs) are critical in managing respiratory conditions characterized by mucus hypersecretion and impaired clearance, such as cystic fibrosis, chronic obstructive pulmonary disease (COPD), and various neuromuscular disorders."</div>
                
                
                <div class="evidence-explanation">The reference discusses the importance of ACTs in managing conditions with mucus hypersecretion and impaired clearance, which aligns with the use of these techniques in PCD.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/11376511" target="_blank">PMID:11376511</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"There are three principal disorders of MCC. Firstly, primary ciliary dyskinesia (PCD)..."</div>
                
                
                <div class="evidence-explanation">The reference mentions PCD and discusses airway hygiene and mucociliary clearance, supporting the relevance of airway clearance techniques in PCD.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box treatment-box">
                <div class="item-name">
                    Antibiotic Therapy
                    
                    <span class="phenotype-id">
                        <a href="https://bioregistry.io/MAXO:0000058" target="_blank">
                            MAXO:0000058
                        </a>
                    </span>
                    
                </div>
                
                
                <div class="item-desc">Long-term or prophylactic antibiotics to control respiratory infections.</div>
                
                
                
                <div class="item-meta" style="margin-top: 8px;">
                    <strong style="font-size: 0.8rem; color: #6b21a8;">Target Phenotypes:</strong>
                    
                    <span class="tag" style="background: #ede9fe; color: #6b21a8; font-size: 0.8rem;">
                        Recurrent Respiratory Infections
                        
                        <a href="http://purl.obolibrary.org/obo/HP_0002205" target="_blank" style="color: inherit; margin-left: 4px;">‚Üó</a>
                        
                    </span>
                    
                </div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (3 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/28552099" target="_blank">PMID:28552099</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Non-functional airway cilia impair the mucociliary clearance (MCC), causing mucostasis, lung infections and destruction, chronic rhinosinusitis (CRS) and hearing impairment. It is of paramount importance to postpone chronic lung infection mainly with Gram-negative bacteria (GNB) in patients with..."</div>
                
                
                <div class="evidence-explanation">The literature mentions the importance of postponing chronic lung infection in patients with impaired MCC, which is a characteristic of PCD. This aligns with the use of long-term antibiotic therapy to manage such infections.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/26586601" target="_blank">PMID:26586601</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Most of the treatments recommended in PCD have been extrapolated from cystic fibrosis (CF) and non-CF bronchiectasis literature. Mainstays of therapy are reviewed in detail, and should include at a minimum: regular airway clearance, routine microbiological surveillance, antibiotic treatment for..."</div>
                
                
                <div class="evidence-explanation">The reference states that antibiotic treatment for pulmonary exacerbation is a mainstay of therapy for PCD, supporting the use of long-term or prophylactic antibiotics.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/19812481" target="_blank">PMID:19812481</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Antibiotic prophylaxis is one of the mainstays of therapy of primary immunodeficiencies."</div>
                
                
                <div class="evidence-explanation">While the focus is on primary immunodeficiencies, the principle of using antibiotic prophylaxis can be extended to PCD due to similar needs for managing chronic infections.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box treatment-box">
                <div class="item-name">
                    Bronchodilators
                    
                    <span class="phenotype-id">
                        <a href="https://bioregistry.io/MAXO:0000058" target="_blank">
                            MAXO:0000058
                        </a>
                    </span>
                    
                </div>
                
                
                <div class="item-desc">Medications to help open airways and ease breathing.</div>
                
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (4 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/36639347" target="_blank">PMID:36639347</a>
                    </span>
                    
                    <span class="evidence-support support-NO_EVIDENCE">NO_EVIDENCE</span>
                    
                    
                </div>
                
                
                <div class="evidence-explanation">The reference discusses new data and future challenges related to Primary Ciliary Dyskinesia (PCD) and bronchiectasis but does not provide specific information about the use of bronchodilators for PCD.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/39269762" target="_blank">PMID:39269762</a>
                    </span>
                    
                    <span class="evidence-support support-NO_EVIDENCE">NO_EVIDENCE</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Primary ciliary dyskinesia (PCD) is a respiratory disorder that impairs mucociliary clearance, leading to decreased lung function."</div>
                
                
                <div class="evidence-explanation">The reference focuses on airway clearance techniques in PCD and does not mention the use of bronchodilators.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/33507585" target="_blank">PMID:33507585</a>
                    </span>
                    
                    <span class="evidence-support support-NO_EVIDENCE">NO_EVIDENCE</span>
                    
                    
                </div>
                
                
                <div class="evidence-explanation">The reference discusses intrapulmonary percussive ventilation for PCD but does not mention bronchodilators.</div>
                
            </div>
            
            
            <div class="evidence-more">+ 1 more reference</div>
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box treatment-box">
                <div class="item-name">
                    Nasal Steroids
                    
                    <span class="phenotype-id">
                        <a href="https://bioregistry.io/MAXO:0000058" target="_blank">
                            MAXO:0000058
                        </a>
                    </span>
                    
                </div>
                
                
                <div class="item-desc">Used to treat nasal polyps and chronic sinusitis.</div>
                
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (4 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/19879441" target="_blank">PMID:19879441</a>
                    </span>
                    
                    <span class="evidence-support support-PARTIAL">PARTIAL</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Long-term treatment with corticosteroid nasal spray reduces inflammation and nasal polyp size, and improves nasal symptoms such as nasal blockage, rhinorrea, and the loss of smell."</div>
                
                
                <div class="evidence-explanation">While nasal steroids are used to treat nasal polyps and chronic rhinosinusitis, the statement should specify that they are used to manage symptoms rather than being a description of Primary Ciliary Dyskinesia (PCD).</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/33305974" target="_blank">PMID:33305974</a>
                    </span>
                    
                    <span class="evidence-support support-PARTIAL">PARTIAL</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Topical nasal steroids play an important role in the treatment of CRS."</div>
                
                
                <div class="evidence-explanation">Nasal steroids are used in the treatment of chronic rhinosinusitis (CRS), which can be a condition associated with PCD. However, the statement should clarify that nasal steroids are for symptom management rather than a direct description of PCD.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/35312075" target="_blank">PMID:35312075</a>
                    </span>
                    
                    <span class="evidence-support support-PARTIAL">PARTIAL</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Our findings indicate for the first time that PCD patients with CRSwNP display a more severe disease than those with CRSsNP."</div>
                
                
                <div class="evidence-explanation">This reference indicates that chronic rhinosinusitis with nasal polyps (CRSwNP) is more severe in PCD patients. However, it does not directly state that nasal steroids are used to treat these conditions in the context of PCD.</div>
                
            </div>
            
            
            <div class="evidence-more">+ 1 more reference</div>
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box treatment-box">
                <div class="item-name">
                    Hearing Aids
                    
                    <span class="phenotype-id">
                        <a href="https://bioregistry.io/MAXO:0000950" target="_blank">
                            MAXO:0000950
                        </a>
                    </span>
                    
                </div>
                
                
                <div class="item-desc">Assistive devices for hearing loss management.</div>
                
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (5 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/29287859" target="_blank">PMID:29287859</a>
                    </span>
                    
                    <span class="evidence-support support-NO_EVIDENCE">NO_EVIDENCE</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"CONCLUSIONS: Slight to mild CHL and all types of otitis media are prevalent among patients with PCD, and some of these children have sensorineural hearing loss (SNHL)."</div>
                
                
                <div class="evidence-explanation">The study discusses the prevalence and types of hearing loss in children with PCD but does not mention the use of hearing aids or other assistive devices for management.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/22960754" target="_blank">PMID:22960754</a>
                    </span>
                    
                    <span class="evidence-support support-NO_EVIDENCE">NO_EVIDENCE</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"This article explores factors pertaining to children&#39;s use of and attitudes toward hearing technologies, such as hearing aids, cochlear implants, teacher-worn microphones, and student-worn microphones."</div>
                
                
                <div class="evidence-explanation">This study focuses on the use of hearing technologies among students with hearing impairment but does not specifically address children with PCD.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/28187057" target="_blank">PMID:28187057</a>
                    </span>
                    
                    <span class="evidence-support support-NO_EVIDENCE">NO_EVIDENCE</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"OBJECTIVE: To evaluate whether wearing auditory assistive devices can improve gait and dynamic balance."</div>
                
                
                <div class="evidence-explanation">The study evaluates the impact of hearing assistive devices on gait and balance in adults but does not mention their use in patients with PCD.</div>
                
            </div>
            
            
            <div class="evidence-more">+ 2 more references</div>
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box treatment-box">
                <div class="item-name">
                    Genetic Counseling
                    
                    <span class="phenotype-id">
                        <a href="https://bioregistry.io/MAXO:0000079" target="_blank">
                            MAXO:0000079
                        </a>
                    </span>
                    
                </div>
                
                
                <div class="item-desc">Provides information and support for affected individuals and families.</div>
                
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (4 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/29800551" target="_blank">PMID:29800551</a>
                    </span>
                    
                    <span class="evidence-support support-NO_EVIDENCE">NO_EVIDENCE</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Our knowledge of cilia genetics and the function of the proteins encoded has led to a greater understanding of the clinical manifestations of motile ciliopathies. These advances have changed our approach toward diagnostic testing for primary ciliary dyskinesia."</div>
                
                
                <div class="evidence-explanation">The reference discusses advances in genetics and diagnostic testing for primary ciliary dyskinesia but does not mention genetic counseling providing information and support for affected individuals and families.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/29905515" target="_blank">PMID:29905515</a>
                    </span>
                    
                    <span class="evidence-support support-NO_EVIDENCE">NO_EVIDENCE</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"This document presents the American Thoracic Society clinical practice guidelines for the diagnosis of primary ciliary dyskinesia (PCD)."</div>
                
                
                <div class="evidence-explanation">The guideline focuses on diagnostic practices and does not mention genetic counseling or support for affected individuals and families.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/19410203" target="_blank">PMID:19410203</a>
                    </span>
                    
                    <span class="evidence-support support-NO_EVIDENCE">NO_EVIDENCE</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Newer genetic modifiers show an exciting potential for personalized medication, combining selection of patients with a common genetic mutation and a drug treatment that has been specifically designed to overcome that mutation, and will greatly enhance the therapeutic arsenal for PCD."</div>
                
                
                <div class="evidence-explanation">The reference discusses potential future therapies for PCD but does not mention genetic counseling or support services.</div>
                
            </div>
            
            
            <div class="evidence-more">+ 1 more reference</div>
            
        </div>
    </details>
    
    
            </div>
            
        </div>
        

        <!-- Environmental Factors -->
        
        <div class="card">
            <div class="card-header">
                <div class="card-icon" style="background: #ccfbf1; color: #0d9488;">üåç</div>
                <h2 class="card-title">Environmental Factors</h2>
                <span class="card-count">1</span>
            </div>
            
            <div class="item-box environmental-box">
                <div class="item-name">Air Pollution</div>
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (2 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/34574829" target="_blank">PMID:34574829</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Air pollution decreases quality of life and life expectancy. It exacerbates acute and chronic respiratory symptoms in patients with chronic airway diseases, and increases the morbidity and risk of hospitalization associated with respiratory diseases."</div>
                
                
                <div class="evidence-explanation">The literature indicates that air pollution exacerbates respiratory symptoms in patients with chronic airway diseases, which can be inferred to include conditions like Primary Ciliary Dyskinesia (PCD).</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/37147124" target="_blank">PMID:37147124</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"CONCLUSIONS: Short-term ambient NO2 and PM2.5 exposure were associated with increased odds of exacerbations in Canadians with mild to moderate COPD, further heightening the awareness of non-infectious triggers of COPD exacerbations"</div>
                
                
                <div class="evidence-explanation">While this study focuses on COPD, it highlights the role of air pollution in exacerbating respiratory conditions, which can be extended to other chronic respiratory diseases like PCD.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
        </div>
        

        <!-- Biochemical Markers -->
        
        <div class="card">
            <div class="card-header">
                <div class="card-icon" style="background: #fef3c7; color: #d97706;">üî¨</div>
                <h2 class="card-title">Biochemical Markers</h2>
                <span class="card-count">1</span>
            </div>
            
            <div class="item-box biochemical-box">
                <div class="item-name">
                    Nitric Oxide
                    
                    <span style="font-size: 0.8rem; font-weight: normal; opacity: 0.8;">(Decreased)</span>
                    
                </div>
                
                <div class="item-desc">Context: Lower levels in nasal and exhaled breath</div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (6 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/12511725" target="_blank">PMID:12511725</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Low values in both eNO and nNO readings (&lt;2.4 ppb and &lt;187 ppb, respectively) identified PCD patients from other bronchiectatic patients with a specificity of 98% and a positive predictive value of 92%."</div>
                
                
                <div class="evidence-explanation">This study shows that both exhaled nitric oxide (eNO) and nasal nitric oxide (nNO) levels are significantly lower in patients with primary ciliary dyskinesia (PCD) compared to other groups.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/22408195" target="_blank">PMID:22408195</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Despite chronic infections, nasal nitric oxide in such patients is markedly reduced and is used as a screening test for this condition."</div>
                
                
                <div class="evidence-explanation">This abstract confirms that nasal nitric oxide levels are significantly reduced in PCD patients.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/31770003" target="_blank">PMID:31770003</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Nasal nitric oxide concentrations are extremely low in primary ciliary dyskinesia (PCD), and measurement of this nasal gas is recommended as a PCD diagnostic test in cooperative patients aged 5 years and older."</div>
                
                
                <div class="evidence-explanation">This paper supports the statement by indicating that nasal nitric oxide levels are extremely low in PCD patients.</div>
                
            </div>
            
            
            <div class="evidence-more">+ 3 more references</div>
            
        </div>
    </details>
    
    
            </div>
            
        </div>
        

        <!-- Differential Diagnoses -->
        

        <!-- Datasets -->
        

        <!-- Clinical Trials -->
        

        <!-- YAML Source -->
        <div class="card">
            <div class="card-header" style="cursor: pointer;" onclick="toggleYaml()">
                <div class="card-icon" style="background: #f1f5f9; color: #475569;">{ }</div>
                <h2 class="card-title">Source YAML</h2>
                <span class="card-count" id="yamlToggleText">click to show</span>
            </div>
            <div class="yaml-content" id="yamlContent">
                <pre class="yaml-preview">name: Primary_Ciliary_Dyskinesia
creation_date: &#39;2025-12-04T16:57:31Z&#39;
updated_date: &#39;2026-02-02T00:09:22Z&#39;
category: Genetic
parents:
- Ciliopathy
- Respiratory Disease
prevalence:
- population: Global
  percentage: 0.025-0.05
  evidence:
  - reference: PMID:34454779
    supports: PARTIAL
    snippet: Primary ciliary dyskinesia (PCD) is a rare hereditary disease.
    explanation: The study mentions that PCD is a rare disease but does not provide specific global prevalence rates.
  - reference: PMID:31971980
    supports: PARTIAL
    snippet: Primary ciliary dyskinesia (PCD) is a rare autosomal recessive disease with low prevalence in pediatrics.
    explanation: The study confirms that PCD is rare but does not provide exact global prevalence figures.
  - reference: PMID:32662935
    supports: PARTIAL
    snippet: Cilia are cell membrane-bound organelles responsible for airway mucus clearance, establishment of left-right organ asymmetry, cardiogenesis, and many other functions in utero.
    explanation: The study discusses the functions of cilia and mentions ciliary dyskinesia but does not provide prevalence data.
  - reference: PMID:30792130
    supports: PARTIAL
    snippet: Primary ciliary dyskinesia (PCD), also known as immotile-cilia syndrome, is a rare genetic disease.
    explanation: The study acknowledges that PCD is a rare genetic disease but does not specify the global prevalence.
  - reference: PMID:26826908
    supports: NO_EVIDENCE
    snippet: Primary Ciliary Dyskinesia.
    explanation: This reference does not provide information on the global prevalence of PCD.
  - reference: PMID:15917207
    supports: NO_EVIDENCE
    snippet: Cilia are classified according to their microtubule components as 9+2 (motile) and 9+0 (primary) cilia.
    explanation: This reference discusses cilia and their functions but does not provide prevalence data for PCD.
  - reference: PMID:29905515
    supports: NO_EVIDENCE
    snippet: This document presents the American Thoracic Society clinical practice guidelines for the diagnosis of primary ciliary dyskinesia (PCD).
    explanation: This reference focuses on diagnostic guidelines and does not provide prevalence data.
  - reference: PMID:31430425
    supports: NO_EVIDENCE
    snippet: The objective of this study was to evaluate the prevalence of chronic rhinosinusitis (CRS) and its characteristics in bronchiectasis patients suspected of harboring ciliary dyskinesia.
    explanation: This study evaluates CRS in patients suspected of having ciliary dyskinesia but does not provide global prevalence data for PCD.
  - reference: PMID:36588099
    supports: NO_EVIDENCE
    snippet: There are no recent data on primary ciliary dyskinesia (PCD) distribution, diagnosis and treatment in Italy.
    explanation: This reference discusses PCD in Italy but does not provide global prevalence data.
pathophysiology:
- name: Ciliary Dysfunction
  description: Defects in the structure and function of motile cilia impair mucociliary clearance.
  genes:
  - preferred_term: DNAI1
    term:
      id: hgnc:2954
      label: DNAI1
  - preferred_term: DNAH5
    term:
      id: hgnc:2950
      label: DNAH5
  cell_types:
  - preferred_term: respiratory ciliated cell
    term:
      id: CL:0002368
      label: respiratory tract epithelial cell
  - preferred_term: ependymal cell
    term:
      id: CL:0000065
      label: ependymal cell
  biological_processes:
  - preferred_term: cilium movement
    term:
      id: GO:0003341
      label: cilium movement
  - preferred_term: cilium assembly
    term:
      id: GO:0060271
      label: cilium assembly
  - preferred_term: axoneme assembly
    term:
      id: GO:0035082
      label: axoneme assembly
  locations:
  - preferred_term: respiratory tract epithelium
    term:
      id: UBERON:0004808
      label: respiratory tract epithelium
  - preferred_term: nasal cavity epithelium
    term:
      id: UBERON:0000398
      label: nasal cavity epithelium
  - preferred_term: trachea
    term:
      id: UBERON:0003126
      label: trachea
  - preferred_term: bronchus
    term:
      id: UBERON:0002185
      label: bronchus
  cellular_components:
  - preferred_term: Cilia
    term:
      id: GO:0005929
      label: cilium
  - preferred_term: axoneme
    term:
      id: GO:0005930
      label: axoneme
  - preferred_term: outer dynein arm
    term:
      id: GO:0036157
      label: outer dynein arm
  downstream:
  - target: Impaired Mucociliary Clearance
  evidence:
  - reference: PMID:19818430
    supports: SUPPORT
    snippet: Primary ciliary dyskinesia is a genetically inherited syndrome characterized by cilia immotility or dysmotility. Deficiency in mucociliary clearance produces chronic respiratory infections since birth.
    explanation: The reference confirms that defects in the structure and function of motile cilia impair mucociliary clearance, supporting the statement.
  - reference: PMID:20525503
    supports: SUPPORT
    snippet: Ciliary dysfunction may be primary, the result of genetic mutations resulting in abnormal cilia structure, or secondary, the result of environmental, infectious or inflammatory stimuli that disrupt normal motility or coordination.
    explanation: This reference supports the statement by indicating that primary ciliary dyskinesia results from genetic mutations affecting cilia structure and function, leading to impaired mucociliary clearance.
  - reference: PMID:17059358
    supports: SUPPORT
    snippet: The most prominent genetic abnormality involving motile cilia (and the respiratory tract) is primary ciliary dyskinesia (PCD). PCD is a rare, usually autosomal recessive, genetically heterogeneous disorder characterized by sino-pulmonary disease, laterality defects, and male infertility.
    explanation: The reference supports the statement by describing PCD as a disorder involving motile cilia defects, which leads to respiratory issues due to impaired mucociliary clearance.
  - reference: PMID:15750039
    supports: SUPPORT
    snippet: Primary ciliary dyskinesia (PCD) is a genetically heterogeneous disorder characterized by recurrent infections of the airways and situs inversus in half of the affected offspring. The most frequent genetic defects comprise recessive mutations of DNAH5 and DNAI1, which encode outer dynein arm (ODA) components.
    explanation: This reference supports the statement by listing DNAH5 and DNAI1 as genes involved in PCD, which is characterized by defects in motile cilia leading to impaired mucociliary clearance.
  - reference: PMID:32185794
    supports: SUPPORT
    snippet: Primary ciliary dyskinesia (PCD) is a genetically heterogeneous disorder characterized by defects in the function or structure of motitle cilia
    explanation: The reference supports the statement by confirming that PCD involves defects in the structure and function of motile cilia, which impair mucociliary clearance.
- name: Impaired Mucociliary Clearance
  description: Failure to effectively remove mucus and pathogens from respiratory passages.
  biological_processes:
  - preferred_term: mucociliary clearance
    term:
      id: GO:0120197
      label: mucociliary clearance
  locations:
  - preferred_term: respiratory system
    term:
      id: UBERON:0001004
      label: respiratory system
  - preferred_term: paranasal sinus
    term:
      id: UBERON:0001825
      label: paranasal sinus
  downstream:
  - target: Chronic Respiratory Infections
  - target: Sinusitis
  - target: Otitis Media
  evidence:
  - reference: PMID:11376511
    supports: SUPPORT
    snippet: Failure to keep the airways sterile by MCC results in a host inflammatory response to the persistent microorganisms which, if it becomes chronic, causes damage to the airway wall and upregulation of mucus production manifest clinically as bronchiectasis, sinusitis and otitis.
    explanation: The literature supports that primary ciliary dyskinesia (PCD) leads to impaired mucociliary clearance, which results in chronic respiratory infections, sinusitis, and otitis media.
  - reference: PMID:17142159
    supports: SUPPORT
    snippet: Primary ciliary dyskinesia is an autosomal recessive genetic disease that results in impaired mucociliary clearance causing progressive involvement of the upper and lower respiratory tract, characterized by airway obstruction and recurrent infections of the lungs, middle ear and paranasal sinuses.
    explanation: The literature supports that primary ciliary dyskinesia leads to impaired mucociliary clearance and downstream chronic respiratory infections, sinusitis, and otitis media.
  - reference: PMID:15917207
    supports: SUPPORT
    snippet: Disruption of 9+2 cilia, which move mucus across respiratory epithelia, leads to rhinitis, sinusitis and bronchiectasis.
    explanation: The literature supports that disruption of motile cilia, as seen in primary ciliary dyskinesia, leads to impaired mucociliary clearance and resultant respiratory conditions such as sinusitis and bronchiectasis.
  - reference: PMID:29490941
    supports: SUPPORT
    snippet: We hypothesised that olfactory function could be impaired in primary ciliary dyskinesia (PCD). Olfaction, nasal nitric oxide (nNO) and sinus CT were assessed in patients with PCD and non-PCD sinus disease, and healthy controls (no CT scan). PCD and non-PCD patients had similar severity of sinus disease.
    explanation: The literature supports that primary ciliary dyskinesia leads to impaired mucociliary clearance and associated conditions such as sinusitis.
- name: Situs Inversus
  description: Abnormal placement of internal organs due to ciliary dysfunction during embryonic development.
  frequency: 50%
  biological_processes:
  - preferred_term: determination of left/right symmetry
    term:
      id: GO:0007368
      label: determination of left/right symmetry
  - preferred_term: nodal cilium assembly
    term:
      id: GO:1904955
      label: motile cilium assembly
  locations:
  - preferred_term: embryo
    term:
      id: UBERON:0000922
      label: embryo
  evidence:
  - reference: PMID:16036877
    supports: PARTIAL
    snippet: The normal left-right asymmetry of the body is thought to be due to the beating of the cilia in the embryonic (Hensen&#39;s) node. Total immotility of the cilia should therefore result in random asymmetry of the body that is situs inversus in 50% of the cases. It has also been claimed that 50% of cases with PCD have situs inversus.
    explanation: The statement is partially supported. The literature confirms that primary ciliary dyskinesia (PCD) can lead to situs inversus due to ciliary dysfunction during embryonic development, and it is claimed that 50% of PCD cases have situs inversus. However, the phrase &#39;abnormal placement of internal organs&#39; is more general and could include other forms of laterality defects, not just situs inversus.
  - reference: PMID:36342963
    supports: PARTIAL
    snippet: &#39;Results: Of 559 participants, 286 (51.2%), 215 (38.5%), and 58 (10.4%) were identified as having situs solitus, situs inversustotalis, and situs ambiguus, respectively; heterotaxy, defined as situs ambiguus with complex cardiovascular defects, was present in 14 (2.5%)&#39;
    explanation: The statement is partially supported. The data shows that 38.5% of PCD cases have situs inversus totalis, which is close to but not exactly 50%. Additionally, there are other laterality defects like situs ambiguus, which are not covered by the statement.
phenotypes:
- category: Respiratory
  name: Chronic Cough
  frequency: VERY_FREQUENT
  diagnostic: true
  evidence:
  - reference: PMID:27258773
    supports: SUPPORT
    snippet: Primary ciliary dyskinesia (PCD) is a rare, heterogeneous, recessive, genetic disorder of motile cilia, leading to chronic upper and lower respiratory symptoms.
    explanation: The statement is supported because PCD leads to chronic respiratory symptoms, including chronic cough.
  - reference: PMID:17142159
    supports: SUPPORT
    snippet: Primary ciliary dyskinesia is an autosomal recessive genetic disease that results in impaired mucociliary clearance causing progressive involvement of the upper and lower respiratory tract, characterized by airway obstruction and recurrent infections of the lungs, middle ear and paranasal sinuses.
    explanation: The statement is supported because PCD causes progressive involvement of the respiratory tract, which includes chronic cough.
  phenotype_term:
    preferred_term: Chronic Cough
    term:
      id: HP:0034315
      label: Chronic cough
- category: Respiratory
  name: Recurrent Respiratory Infections
  frequency: VERY_FREQUENT
  evidence:
  - reference: PMID:39069333
    supports: SUPPORT
    snippet: This review article explores the respiratory aspects of primary ciliary dyskinesia (PCD), a rare, heterogenous, genetic disorder characterized by impaired motile ciliary function. It discusses the clinical diagnosis and management strategies for PCD-related respiratory disease, including chronic sinusitis, otitis media with effusion, recurrent pneumonia, and bronchiectasis.
    explanation: The article discusses recurrent respiratory diseases as a significant aspect of PCD, supporting the statement that recurrent respiratory infections are very frequent in PCD.
  - reference: PMID:36214320
    supports: SUPPORT
    snippet: &#39;Ninety-two children with chronic respiratory symptoms were divided into 4 groups: 18 children with refractory asthma, 10 with bronchiectasis without dextrocardia, 18 with dextrocardia and 46 with recurrent respiratory tract infections.&#39;
    explanation: The study highlights recurrent respiratory tract infections in children with chronic respiratory symptoms, supporting the statement that recurrent respiratory infections are very frequent in PCD.
  - reference: PMID:31430425
    supports: SUPPORT
    snippet: The objective of this study was to evaluate the prevalence of chronic rhinosinusitis (CRS) and its characteristics in bronchiectasis patients suspected of harboring ciliary dyskinesia.
    explanation: The study mentions chronic rhinosinusitis and bronchiectasis in patients suspected of ciliary dyskinesia, indicating frequent respiratory issues.
  - reference: PMID:25370419
    supports: SUPPORT
    snippet: The sinuses should be considered as a bacterial reservoir and a target for surgery and antibiotic treatment in patients with primary ciliary dyskinesia (PCD).
    explanation: The study discusses sinus infections as a common issue in PCD, supporting the statement about frequent respiratory infections.
  phenotype_term:
    preferred_term: Recurrent Respiratory Infections
    term:
      id: HP:0002205
      label: Recurrent respiratory infections
- category: Respiratory
  name: Bronchiectasis
  frequency: FREQUENT
  evidence:
  - reference: PMID:10894096
    supports: SUPPORT
    snippet: Patients with primary ciliary dyskinesia could potentially develop recurrent sinotrachrobronchitis, bronchiectasis, serous otitis media, hydrocephalus, and male infertility.
    explanation: The article mentions bronchiectasis as one of the potential conditions that patients with PCD could develop.
  - reference: PMID:36344229
    supports: SUPPORT
    snippet: Typical manifestations include bronchiectasis, secretory otitis media, sinusitis, situs inversus, and infertility.
    explanation: The article lists bronchiectasis as a typical manifestation of primary ciliary dyskinesia.
  - reference: PMID:25673230
    supports: SUPPORT
    snippet: Primary ciliary dyskinesia (PCD) is a rare disease, characterised by chronic airway infection.
    explanation: The article discusses the relationship between functional and structural abnormalities in PCD, including bronchiectasis.
  - reference: PMID:21680564
    supports: SUPPORT
    snippet: A review is presented of key clinical papers published in Thorax and elsewhere between 2008 and April 2011 which have advanced our understanding of cystic fibrosis (CF), primary ciliary dyskinesia and non-CF bronchiectasis.
    explanation: The article discusses primary ciliary dyskinesia and non-CF bronchiectasis, implying a connection between PCD and bronchiectasis.
  - reference: PMID:31430425
    supports: SUPPORT
    snippet: The objective of this study was to evaluate the prevalence of chronic rhinosinusitis (CRS) and its characteristics in bronchiectasis patients suspected of harboring ciliary dyskinesia.
    explanation: The study evaluates bronchiectasis in patients suspected of having ciliary dyskinesia, indicating a frequent association.
  - reference: PMID:37278553
    supports: SUPPORT
    snippet: Primary ciliary dyskinesia as a common cause of bronchiectasis in the Canadian Inuit population.
    explanation: The article explicitly states that PCD is a common cause of bronchiectasis in a specific population.
  - reference: PMID:33895745
    supports: SUPPORT
    snippet: Primary ciliary dyskinesia (PCD) is a rare genetic disorder which requires a complex diagnostic workup. Thus, an easy and widely available screening method would be helpful to identify patients who need a further diagnostic workup for PCD.
    explanation: The article discusses the need for diagnostic workup for PCD in patients with bronchiectasis, indicating a frequent association.
  - reference: PMID:23181248
    supports: SUPPORT
    snippet: Mucociliary clearance is a primary defence mechanism of the airway that can be altered in congenital diseases such as primary ciliary dyskinesia and cystic fibrosis, as well as acquired conditions.
    explanation: The article focuses on primary ciliary dyskinesia and its impact on mucociliary clearance, which is related to bronchiectasis.
  - reference: PMID:37852905
    supports: NO_EVIDENCE
    snippet: &#39;Bardet-Biedl Syndrome: An Uncommon Cause of Bronchiectasis.&#39;
    explanation: The article discusses Bardet-Biedl Syndrome as a cause of bronchiectasis, not primary ciliary dyskinesia.
  phenotype_term:
    preferred_term: Bronchiectasis
    term:
      id: HP:0002110
      label: Bronchiectasis
- category: Otologic
  name: Chronic Otitis Media
  frequency: FREQUENT
  evidence:
  - reference: PMID:29135867
    supports: SUPPORT
    snippet: All 15 patients showed ciliary ultrastructural abnormalities on electron microscopy and/or biallelic mutations in genes associated with ciliary function or structure. All 30 eardrums examined showed certain abnormalities. Fourteen patients had otitis media with effusion or its sequelae. The remaining patient had chronic otitis media.
    explanation: The study found that patients with primary ciliary dyskinesia (PCD) frequently exhibited otologic issues, including chronic otitis media.
  - reference: PMID:19796826
    supports: SUPPORT
    snippet: Primary ciliary dyskinesia is an autosomal recessively inherited group of disorders of ciliary ultrastructure. Otolaryngologists are frequently involved in the management of some of the most common symptoms of primary ciliary dyskinesia including chronic rhinitis, sinusitis and otitis media with effusion.
    explanation: This reference supports that chronic otitis media and other otologic issues are common in patients with primary ciliary dyskinesia.
  phenotype_term:
    preferred_term: Chronic Otitis Media
    term:
      id: HP:0000389
      label: Chronic otitis media
- category: Otologic
  name: Hearing Loss
  frequency: OCCASIONAL
  evidence:
  - reference: PMID:29287859
    supports: REFUTE
    snippet: Slight to mild CHL and all types of otitis media are prevalent among patients with PCD, and some of these children have sensorineural hearing loss (SNHL).
    explanation: The study indicates that hearing loss is a prevalent condition among patients with primary ciliary dyskinesia (PCD), not occasional.
  - reference: PMID:9222635
    supports: REFUTE
    snippet: All children (11 patients) had bilateral otitis media with effusion. Of the five adults, three had tympanosclerosis; one had bilateral cholesteatoma; and one patient had bilateral keratosis obturans in combination with tympanosclerosis.
    explanation: The study describes otological manifestations including hearing loss as a prominent feature in patients with PCD, suggesting it is not occasional but rather common.
  - reference: PMID:33844744
    supports: NO_EVIDENCE
    snippet: In this group of patients with OI, 30% had hearing loss and among those ears with normal hearing, 13% did not have an acoustic stapedial reflex.
    explanation: This study discusses hearing loss in osteogenesis imperfecta (OI), not primary ciliary dyskinesia (PCD).
  phenotype_term:
    preferred_term: Hearing Loss
    term:
      id: HP:0000365
      label: Hearing impairment
- category: Gastrointestinal
  name: Nasal Polyps
  frequency: FREQUENT
  evidence:
  - reference: PMID:37997295
    supports: NO_EVIDENCE
    snippet: Despite endoscopic differences, PCD-CRS and cystic fibrosis-related chronic rhinosinusitis (CF-CRS) had similar structured histopathology reports. Compared to healthy patients and those with idiopathic chronic rhinosinusitis without nasal polyps, patients with PCD-CRS had an increased neutrophil count.
    explanation: The abstract discusses histopathology and neutrophil count in PCD-CRS, but does not provide evidence on the frequency of nasal polyps in PCD.
  - reference: PMID:39069333
    supports: NO_EVIDENCE
    snippet: This review article explores the respiratory aspects of primary ciliary dyskinesia (PCD), a rare, heterogenous, genetic disorder characterized by impaired motile ciliary function. It discusses the clinical diagnosis and management strategies for PCD-related respiratory disease, including chronic sinusitis, otitis media with effusion, recurrent pneumonia, and bronchiectasis.
    explanation: The review focuses on respiratory aspects of PCD and does not mention nasal polyps as a frequent gastrointestinal manifestation.
- category: Cardiac
  name: Situs Inversus Totalis
  frequency: OCCASIONAL
  evidence:
  - reference: PMID:16036877
    supports: PARTIAL
    snippet: Total immotility of the cilia should therefore result in random asymmetry of the body that is situs inversus in 50% of the cases. It has also been claimed that 50% of cases with PCD have situs inversus.
    explanation: The literature indicates that situs inversus, including situs inversus totalis, occurs in approximately 50% of primary ciliary dyskinesia (PCD) cases. This suggests that it is not merely &#39;occasional&#39; but rather relatively common in PCD patients.
  - reference: PMID:36342963
    supports: PARTIAL
    snippet: &#39;Results: Of 559 participants, 286 (51.2%), 215 (38.5%), and 58 (10.4%) were identified as having situs solitus, situs inversustotalis, and situs ambiguus, respectively; heterotaxy, defined as situs ambiguus with complex cardiovascular defects, was present in 14 (2.5%)&#39;
    explanation: The data indicates that situs inversus totalis occurs in 38.5% of PCD cases, which is more frequent than &#39;occasional.&#39;
  - reference: PMID:38072392
    supports: PARTIAL
    snippet: The remaining 355 participants did not have SA, including 152 with SIT and 203 with SS.
    explanation: Situs inversus totalis (SIT) is present in a significant portion of PCD cases, indicating it is more common than &#39;occasional.&#39;
  phenotype_term:
    preferred_term: Situs Inversus Totalis
    term:
      id: HP:0001696
      label: Situs inversus totalis
- category: Respiratory
  name: Chronic Respiratory Infections
  frequency: FREQUENT
  phenotype_term:
    preferred_term: Chronic Respiratory Infections
    term:
      id: HP:0002205
      label: Recurrent respiratory infections
- category: Respiratory
  name: Sinusitis
  frequency: FREQUENT
  phenotype_term:
    preferred_term: Sinusitis
    term:
      id: HP:0000246
      label: Sinusitis
- category: Otologic
  name: Otitis Media
  frequency: FREQUENT
  phenotype_term:
    preferred_term: Otitis Media
    term:
      id: HP:0000388
      label: Otitis media
- category: Respiratory
  name: Neonatal Respiratory Distress
  frequency: FREQUENT
  notes: Common presenting feature in newborns with PCD
  phenotype_term:
    preferred_term: Neonatal respiratory distress
    term:
      id: HP:0002643
      label: Neonatal respiratory distress
- category: Reproductive
  name: Male Infertility
  frequency: FREQUENT
  notes: Due to sperm flagellar defects affecting motility
  phenotype_term:
    preferred_term: Male infertility
    term:
      id: HP:0003251
      label: Male infertility
- category: Respiratory
  name: Chronic Rhinosinusitis
  frequency: VERY_FREQUENT
  notes: Chronic inflammation of nasal passages and sinuses
  phenotype_term:
    preferred_term: Chronic rhinosinusitis
    term:
      id: HP:0011109
      label: Chronic sinusitis
biochemical:
- name: Nitric Oxide
  presence: Decreased
  context: Lower levels in nasal and exhaled breath
  evidence:
  - reference: PMID:12511725
    supports: SUPPORT
    snippet: Low values in both eNO and nNO readings (&lt;2.4 ppb and &lt;187 ppb, respectively) identified PCD patients from other bronchiectatic patients with a specificity of 98% and a positive predictive value of 92%.
    explanation: This study shows that both exhaled nitric oxide (eNO) and nasal nitric oxide (nNO) levels are significantly lower in patients with primary ciliary dyskinesia (PCD) compared to other groups.
  - reference: PMID:22408195
    supports: SUPPORT
    snippet: Despite chronic infections, nasal nitric oxide in such patients is markedly reduced and is used as a screening test for this condition.
    explanation: This abstract confirms that nasal nitric oxide levels are significantly reduced in PCD patients.
  - reference: PMID:31770003
    supports: SUPPORT
    snippet: Nasal nitric oxide concentrations are extremely low in primary ciliary dyskinesia (PCD), and measurement of this nasal gas is recommended as a PCD diagnostic test in cooperative patients aged 5 years and older.
    explanation: This paper supports the statement by indicating that nasal nitric oxide levels are extremely low in PCD patients.
  - reference: PMID:35777446
    supports: SUPPORT
    snippet: We hypothesized that differences in nasal nitric oxide (nNO) and fractional exhaled nitric oxide (Feno) relate to prognosis in primary ciliary dyskinesia (PCD).
    explanation: The study indicates that both nasal nitric oxide (nNO) and fractional exhaled nitric oxide (FeNO) levels are low in PCD patients and are used to monitor the condition.
  - reference: PMID:33860637
    supports: SUPPORT
    snippet: Nasal nitric oxide (nNO) measurement is recommended to screen for Primary Ciliary Dyskinesia (PCD) in subjects with suggestive history and symptoms.
    explanation: This study supports the statement by recommending nasal nitric oxide measurement as a screening tool for PCD due to its low levels in such patients.
  - reference: PMID:29490941
    supports: SUPPORT
    snippet: Olfaction, nasal nitric oxide (nNO) and sinus CT were assessed in patients with PCD and non-PCD sinus disease, and healthy controls (no CT scan).
    explanation: The study confirms that nasal nitric oxide levels are lower in PCD patients compared to non-PCD patients.
genetic:
- name: DNAI1
  association: Pathogenic Variants
  notes: Outer dynein arm intermediate chain required for ODA integrity and docking
  evidence:
  - reference: PMID:11893720
    supports: SUPPORT
    snippet: Mutations in DNAI1 (IC78) cause primary ciliary dyskinesia.
    explanation: This study directly links mutations in DNAI1 to the cause of primary ciliary dyskinesia.
  - reference: PMID:35869935
    supports: SUPPORT
    snippet: 13 rare variants were identified in patients with PCD, among which were three homozygous causative variants (including one splicing variant) in the PCD-associated genes CCDC40 and DNAI1.
    explanation: The study identifies causative variants in DNAI1 associated with primary ciliary dyskinesia.
  - reference: PMID:15750039
    supports: SUPPORT
    snippet: The most frequent genetic defects comprise recessive mutations of DNAH5 and DNAI1, which encode outer dynein arm (ODA) components.
    explanation: This study mentions DNAI1 mutations as frequent genetic defects causing primary ciliary dyskinesia.
  - reference: PMID:11231901
    supports: SUPPORT
    snippet: We identified compound heterozygous DNAI1 gene defects in three independent patients and in two of their siblings who presented with PCD and situs solitus.
    explanation: The study links compound heterozygous DNAI1 gene defects with primary ciliary dyskinesia.
- name: DNAH5
  association: Pathogenic Variants
  notes: Major axonemal outer dynein arm heavy chain generating motile force
  evidence:
  - reference: PMID:31118369
    supports: SUPPORT
    snippet: A genetic examination detected compound heterozygous mutations of DNAH5 that encode ODA components.
    explanation: The study reports a case of primary ciliary dyskinesia (PCD) with DNAH5 mutations, confirming the association between PCD and pathogenic variants in DNAH5.
  - reference: PMID:36727596
    supports: SUPPORT
    snippet: Most PCD-causing variants result in abnormal outer dynein arms (ODAs), which provide the generative force for respiratory ciliary beating and proper mucociliary clearance.
    explanation: The study indicates that pathogenic variants causing PCD often result in abnormal ODAs, which are associated with DNAH5.
- name: DNAH11
  association: Pathogenic Variants
  notes: Outer dynein arm heavy chain often causing dyskinetic beating with near-normal ultrastructure; associated with milder lung function decline
- name: CCDC39
  association: Pathogenic Variants
  notes: Nexin-dynein regulatory complex scaffold for inner dynein arms; associated with severe early lung disease and low lung function
- name: CCDC40
  association: Pathogenic Variants
  notes: Nexin-dynein regulatory complex scaffold partnering with CCDC39; associated with severe lung function decline and possible congenital heart disease
- name: RSPH1
  association: Pathogenic Variants
  notes: Radial spoke head component coordinating central pair-dynein regulation
- name: RSPH4A
  association: Pathogenic Variants
  notes: Radial spoke protein required for radial spoke integrity and coordinated beating
- name: RSPH9
  association: Pathogenic Variants
  notes: Radial spoke head subunit impacting central pair-radial spoke interactions
- name: CCNO
  association: Pathogenic Variants
  notes: Required for centriole amplification and multiciliogenesis; associated with oligocilia and very severe early disease with very low lung function
- name: FOXJ1
  association: Pathogenic Variants
  notes: Master transcription factor regulating motile ciliogenesis; can present in autosomal dominant fashion
- name: MCIDAS
  association: Pathogenic Variants
  notes: Drives multiciliated cell differentiation and centriole biogenesis; associated with reduced cilia number
- name: ODAD1
  association: Pathogenic Variants
  notes: Outer dynein arm docking/assembly factor; associated with relatively milder lung function impact
diagnosis:
- name: High-Speed Video Microscopy
  notes: Assess ciliary motion and structure
  evidence:
  - reference: PMID:38607006
    supports: SUPPORT
    snippet: Our study implemented HSVA for the first time on the island as a tool to better diagnose and characterize the RSPH4A ... founder mutation in Puerto Rican patients.
    explanation: The study demonstrates the use of High-Speed Video Microscopy Analysis (HSVA) to assess ciliary motion and pattern in patients with Primary Ciliary Dyskinesia (PCD).
  - reference: PMID:29493257
    supports: SUPPORT
    snippet: Application of imaging modalities including transmission electron microscopy, high-speed video microscopy, and micron-optical coherence tomography could improve diagnostics and be applied for precision medicine.
    explanation: The review discusses the application of high-speed video microscopy among other imaging modalities to improve diagnostics in ciliopathic diseases, including PCD.
  - reference: PMID:26362507
    supports: SUPPORT
    snippet: We particularly focus on use of high-speed video analysis, transmission electron microscopy, nasal nitric oxide and genetic testing.
    explanation: The review highlights high-speed video analysis as one of the diagnostic methods for Primary Ciliary Dyskinesia.
- name: Transmission Electron Microscopy
  notes: Examines ciliary ultrastructure for diagnostic defects
  evidence:
  - reference: PMID:28915070
    supports: PARTIAL
    snippet: Transmission electron microscopy (TEM) of respiratory cilia was previously considered the gold standard diagnostic test for PCD, but 30% of all PCD cases have either normal ciliary ultrastructure or subtle changes which are non-diagnostic.
    explanation: While TEM examines ciliary ultrastructure and can detect certain defects, it is not definitive for all cases of PCD, as some genetic mutations result in normal or non-diagnostic ultrastructure.
  - reference: PMID:10894096
    supports: SUPPORT
    snippet: This brief article discusses application of the saccharine test, light microscopy assessment of ciliary beat, and transmission electron microscopy assessment of the ultrastructure of cilia.
    explanation: The reference supports that TEM is used to assess ciliary ultrastructure for diagnostic purposes.
  - reference: PMID:28891733
    supports: SUPPORT
    snippet: Routine diagnostic electron microscopy of primary ciliary dyskinesia (PCD) is based on the findings of ultrastructural defects of axonemal components.
    explanation: This reference confirms that TEM is used to examine ciliary ultrastructure for diagnostic defects in PCD.
- name: Nasal Nitric Oxide Test
  notes: Measures nasal nitric oxide levels, typically decreased in PCD patients
  evidence:
  - reference: PMID:31770003
    supports: SUPPORT
    snippet: Nasal nitric oxide concentrations are extremely low in primary ciliary dyskinesia (PCD), and measurement of this nasal gas is recommended as a PCD diagnostic test in cooperative patients aged 5 years and older.
    explanation: The abstract clearly states that nasal nitric oxide concentrations are extremely low in PCD and that measuring this gas is recommended as a diagnostic test.
  - reference: PMID:29490941
    supports: SUPPORT
    snippet: Only in classical PCD did olfaction inversely correlate with sinusitis and nNO.
    explanation: The study mentions that nasal nitric oxide (nNO) levels are involved in the diagnosis of PCD.
  - reference: PMID:36285978
    supports: SUPPORT
    snippet: The nNO level differentiated homozygous subjects with PCD due to the RSPH4A (c.921+3_921+6del (intronic)) founder mutation compared to healthy gender-age matched controls and subjects with VUS or negative genetic testing for PCD.
    explanation: The study demonstrates that nNO levels can differentiate PCD patients from healthy controls and those with other conditions.
  - reference: PMID:37385806
    supports: SUPPORT
    snippet: nNO values were significantly lower in children with PCD than in PCD symptom-similar group and nNO normal controls.
    explanation: The study supports that nasal nitric oxide levels are significantly lower in children with PCD, making it a useful diagnostic tool.
  - reference: PMID:22408195
    supports: SUPPORT
    snippet: Despite chronic infections, nasal nitric oxide in such patients is markedly reduced and is used as a screening test for this condition.
    explanation: The abstract confirms that nasal nitric oxide levels are markedly reduced in PCD patients and are used as a screening test.
environmental:
- name: Air Pollution
  effect: Exacerbates Symptoms
  evidence:
  - reference: PMID:34574829
    supports: SUPPORT
    snippet: Air pollution decreases quality of life and life expectancy. It exacerbates acute and chronic respiratory symptoms in patients with chronic airway diseases, and increases the morbidity and risk of hospitalization associated with respiratory diseases.
    explanation: The literature indicates that air pollution exacerbates respiratory symptoms in patients with chronic airway diseases, which can be inferred to include conditions like Primary Ciliary Dyskinesia (PCD).
  - reference: PMID:37147124
    supports: SUPPORT
    snippet: &#39;CONCLUSIONS: Short-term ambient NO2 and PM2.5 exposure were associated with increased odds of exacerbations in Canadians with mild to moderate COPD, further heightening the awareness of non-infectious triggers of COPD exacerbations&#39;
    explanation: While this study focuses on COPD, it highlights the role of air pollution in exacerbating respiratory conditions, which can be extended to other chronic respiratory diseases like PCD.
  exposure_term:
    preferred_term: Air pollution exposure
    term:
      id: ECTO:8000036
      label: exposure to air pollution
treatments:
- name: Airway Clearance Techniques
  description: Methods to help clear mucus from the lungs, such as chest physical therapy.
  evidence:
  - reference: PMID:28408202
    supports: SUPPORT
    snippet: Airway clearance techniques (ACTs) are commonly recommended for patients with PCD to facilitate mucus clearance, despite a lack of evidence in this group.
    explanation: The reference acknowledges the use of airway clearance techniques in patients with Primary Ciliary Dyskinesia (PCD) to help clear mucus from the lungs.
  - reference: PMID:38861625
    supports: SUPPORT
    snippet: Airway clearance techniques (ACTs) are critical in managing respiratory conditions characterized by mucus hypersecretion and impaired clearance, such as cystic fibrosis, chronic obstructive pulmonary disease (COPD), and various neuromuscular disorders.
    explanation: The reference discusses the importance of ACTs in managing conditions with mucus hypersecretion and impaired clearance, which aligns with the use of these techniques in PCD.
  - reference: PMID:11376511
    supports: SUPPORT
    snippet: There are three principal disorders of MCC. Firstly, primary ciliary dyskinesia (PCD)...
    explanation: The reference mentions PCD and discusses airway hygiene and mucociliary clearance, supporting the relevance of airway clearance techniques in PCD.
  treatment_term:
    preferred_term: physical therapy
    term:
      id: MAXO:0000011
      label: physical therapy
- name: Antibiotic Therapy
  description: Long-term or prophylactic antibiotics to control respiratory infections.
  target_phenotypes:
  - preferred_term: Recurrent Respiratory Infections
    term:
      id: HP:0002205
      label: Recurrent respiratory infections
  evidence:
  - reference: PMID:28552099
    supports: SUPPORT
    snippet: Non-functional airway cilia impair the mucociliary clearance (MCC), causing mucostasis, lung infections and destruction, chronic rhinosinusitis (CRS) and hearing impairment. It is of paramount importance to postpone chronic lung infection mainly with Gram-negative bacteria (GNB) in patients with an impaired MCC. When successful, lung function can be stabilized and quality of life (QoL) improved.
    explanation: The literature mentions the importance of postponing chronic lung infection in patients with impaired MCC, which is a characteristic of PCD. This aligns with the use of long-term antibiotic therapy to manage such infections.
  - reference: PMID:26586601
    supports: SUPPORT
    snippet: &#39;Most of the treatments recommended in PCD have been extrapolated from cystic fibrosis (CF) and non-CF bronchiectasis literature. Mainstays of therapy are reviewed in detail, and should include at a minimum: regular airway clearance, routine microbiological surveillance, antibiotic treatment for pulmonary exacerbation, and health vaccinations.&#39;
    explanation: The reference states that antibiotic treatment for pulmonary exacerbation is a mainstay of therapy for PCD, supporting the use of long-term or prophylactic antibiotics.
  - reference: PMID:19812481
    supports: SUPPORT
    snippet: Antibiotic prophylaxis is one of the mainstays of therapy of primary immunodeficiencies.
    explanation: While the focus is on primary immunodeficiencies, the principle of using antibiotic prophylaxis can be extended to PCD due to similar needs for managing chronic infections.
  treatment_term:
    preferred_term: pharmacotherapy
    term:
      id: MAXO:0000058
      label: pharmacotherapy
- name: Bronchodilators
  description: Medications to help open airways and ease breathing.
  evidence:
  - reference: PMID:36639347
    supports: NO_EVIDENCE
    snippet: &#39;&#39;
    explanation: The reference discusses new data and future challenges related to Primary Ciliary Dyskinesia (PCD) and bronchiectasis but does not provide specific information about the use of bronchodilators for PCD.
  - reference: PMID:39269762
    supports: NO_EVIDENCE
    snippet: Primary ciliary dyskinesia (PCD) is a respiratory disorder that impairs mucociliary clearance, leading to decreased lung function.
    explanation: The reference focuses on airway clearance techniques in PCD and does not mention the use of bronchodilators.
  - reference: PMID:33507585
    supports: NO_EVIDENCE
    snippet: &#39;&#39;
    explanation: The reference discusses intrapulmonary percussive ventilation for PCD but does not mention bronchodilators.
  - reference: PMID:37449771
    supports: NO_EVIDENCE
    snippet: &#39;&#39;
    explanation: The reference discusses treatment response to pulmonary exacerbation in PCD but does not mention bronchodilators.
  treatment_term:
    preferred_term: pharmacotherapy
    term:
      id: MAXO:0000058
      label: pharmacotherapy
- name: Nasal Steroids
  description: Used to treat nasal polyps and chronic sinusitis.
  evidence:
  - reference: PMID:19879441
    supports: PARTIAL
    snippet: Long-term treatment with corticosteroid nasal spray reduces inflammation and nasal polyp size, and improves nasal symptoms such as nasal blockage, rhinorrea, and the loss of smell.
    explanation: While nasal steroids are used to treat nasal polyps and chronic rhinosinusitis, the statement should specify that they are used to manage symptoms rather than being a description of Primary Ciliary Dyskinesia (PCD).
  - reference: PMID:33305974
    supports: PARTIAL
    snippet: Topical nasal steroids play an important role in the treatment of CRS.
    explanation: Nasal steroids are used in the treatment of chronic rhinosinusitis (CRS), which can be a condition associated with PCD. However, the statement should clarify that nasal steroids are for symptom management rather than a direct description of PCD.
  - reference: PMID:35312075
    supports: PARTIAL
    snippet: Our findings indicate for the first time that PCD patients with CRSwNP display a more severe disease than those with CRSsNP.
    explanation: This reference indicates that chronic rhinosinusitis with nasal polyps (CRSwNP) is more severe in PCD patients. However, it does not directly state that nasal steroids are used to treat these conditions in the context of PCD.
  - reference: PMID:28552099
    supports: PARTIAL
    snippet: Implementing ESS with adjuvant therapy to PCD patients (I, IV) significantly ameliorated CRS symptoms.
    explanation: This reference suggests that surgical and adjuvant therapies, including possibly nasal steroids, can ameliorate CRS symptoms in PCD patients. However, it does not explicitly state the use of nasal steroids.
  treatment_term:
    preferred_term: pharmacotherapy
    term:
      id: MAXO:0000058
      label: pharmacotherapy
- name: Hearing Aids
  description: Assistive devices for hearing loss management.
  evidence:
  - reference: PMID:29287859
    supports: NO_EVIDENCE
    snippet: &#39;CONCLUSIONS: Slight to mild CHL and all types of otitis media are prevalent among patients with PCD, and some of these children have sensorineural hearing loss (SNHL).&#39;
    explanation: The study discusses the prevalence and types of hearing loss in children with PCD but does not mention the use of hearing aids or other assistive devices for management.
  - reference: PMID:22960754
    supports: NO_EVIDENCE
    snippet: This article explores factors pertaining to children&#39;s use of and attitudes toward hearing technologies, such as hearing aids, cochlear implants, teacher-worn microphones, and student-worn microphones.
    explanation: This study focuses on the use of hearing technologies among students with hearing impairment but does not specifically address children with PCD.
  - reference: PMID:28187057
    supports: NO_EVIDENCE
    snippet: &#39;OBJECTIVE: To evaluate whether wearing auditory assistive devices can improve gait and dynamic balance.&#39;
    explanation: The study evaluates the impact of hearing assistive devices on gait and balance in adults but does not mention their use in patients with PCD.
  - reference: PMID:30827358
    supports: NO_EVIDENCE
    snippet: Implantable auditory devices (IADs) are a viable hearing restoration option for patients with hearing loss.
    explanation: The article discusses implantable auditory devices as a hearing restoration option but does not specifically mention hearing aids for patients with PCD.
  - reference: PMID:2062156
    supports: NO_EVIDENCE
    snippet: In patients with primary ciliary dyskinesia, a discrepancy was found between subjective ear complaints and the actual middle ear function.
    explanation: This study discusses middle ear function in patients with PCD but does not mention the use of hearing aids or other assistive devices.
  treatment_term:
    preferred_term: supportive care
    term:
      id: MAXO:0000950
      label: supportive care
- name: Genetic Counseling
  description: Provides information and support for affected individuals and families.
  evidence:
  - reference: PMID:29800551
    supports: NO_EVIDENCE
    snippet: Our knowledge of cilia genetics and the function of the proteins encoded has led to a greater understanding of the clinical manifestations of motile ciliopathies. These advances have changed our approach toward diagnostic testing for primary ciliary dyskinesia.
    explanation: The reference discusses advances in genetics and diagnostic testing for primary ciliary dyskinesia but does not mention genetic counseling providing information and support for affected individuals and families.
  - reference: PMID:29905515
    supports: NO_EVIDENCE
    snippet: This document presents the American Thoracic Society clinical practice guidelines for the diagnosis of primary ciliary dyskinesia (PCD).
    explanation: The guideline focuses on diagnostic practices and does not mention genetic counseling or support for affected individuals and families.
  - reference: PMID:19410203
    supports: NO_EVIDENCE
    snippet: Newer genetic modifiers show an exciting potential for personalized medication, combining selection of patients with a common genetic mutation and a drug treatment that has been specifically designed to overcome that mutation, and will greatly enhance the therapeutic arsenal for PCD.
    explanation: The reference discusses potential future therapies for PCD but does not mention genetic counseling or support services.
  - reference: PMID:35854386
    supports: NO_EVIDENCE
    snippet: Diagnostic delay and under-recognition of PCD remain a big issue in China, which contributes to progressive lung disease and PA infection indicating worse outcome.
    explanation: The reference discusses diagnostic delays and clinical outcomes but does not mention genetic counseling or support services.
  treatment_term:
    preferred_term: genetic counseling
    term:
      id: MAXO:0000079
      label: genetic counseling
disease_term:
  preferred_term: primary ciliary dyskinesia
  term:
    id: MONDO:0016575
    label: primary ciliary dyskinesia
classifications:
  harrisons_chapter:
  - classification_value: respiratory system disorder
  - classification_value: hereditary disease
  mechanistic_category:
  - classification_value: ciliopathy
</pre>
            </div>
        </div>

        <footer class="page-footer">
            <p>
                Generated from <a href="https://github.com/monarch-initiative/dismech" target="_blank">dismech</a>
                knowledge base
            </p>
            <p style="margin-top: 8px;">
                <a href="https://github.com/monarch-initiative/dismech/blob/main/kb/disorders/Primary_Ciliary_Dyskinesia.yaml" target="_blank">View source on GitHub</a>
            </p>
        </footer>
    </div>

    <script>
        function toggleYaml() {
            const content = document.getElementById('yamlContent');
            const toggleText = document.getElementById('yamlToggleText');
            content.classList.toggle('show');
            toggleText.textContent = content.classList.contains('show') ? 'click to hide' : 'click to show';
        }
    </script>
    <script>
        (function() {
            const banner = document.querySelector('.notice-banner');
            if (!banner) return;
            const dismiss = () => banner.remove();
            banner.addEventListener('click', dismiss);
            banner.addEventListener('keydown', (event) => {
                if (event.key === 'Enter' || event.key === ' ') {
                    event.preventDefault();
                    dismiss();
                }
            });
        })();
    </script>
</body>
</html>